<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Br. J. Nutr</journal-id><journal-id journal-id-type="publisher-id">BJN</journal-id><journal-title-group><journal-title>The British Journal of Nutrition</journal-title></journal-title-group><issn pub-type="ppub">0007-1145</issn><issn pub-type="epub">1475-2662</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28122649</article-id><article-id pub-id-type="pmc">5297582</article-id><article-id pub-id-type="doi">10.1017/S0007114516003895</article-id><article-id pub-id-type="pii">S0007114516003895</article-id><article-id pub-id-type="publisher-id">00389</article-id><article-categories><subj-group subj-group-type="heading"><subject>Full Papers</subject></subj-group><subj-group subj-group-type="section"><subject>Human and Clinical Nutrition</subject></subj-group></article-categories><title-group><article-title>Serum and macular response to carotenoid-enriched egg supplementation in
human subjects: the Egg Xanthophyll Intervention clinical Trial (EXIT)</article-title><alt-title alt-title-type="left-running">D. Kelly <italic>et al</italic>.</alt-title><alt-title alt-title-type="right-running">Lutein and
<italic>meso</italic>-zeaxanthin-enriched egg trial</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kelly</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Nolan</surname><given-names>John M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Howard</surname><given-names>Alan N.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Stack</surname><given-names>Jim</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6683-249X</contrib-id><name><surname>Akuffo</surname><given-names>Kwadwo O.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Moran</surname><given-names>Rachel</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Thurnham</surname><given-names>David I.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Dennison</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Meagher</surname><given-names>Katherine A.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Beatty</surname><given-names>Stephen</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Macular Pigment Research Group</addr-line>, <addr-line>Nutrition Research Centre
Ireland</addr-line>, <addr-line>School of Health Sciences</addr-line>,
<institution>Waterford Institute of Technology</institution>, <addr-line>Waterford X91
K236</addr-line>, <country>Republic of Ireland</country></aff><aff id="aff2"><label>2</label><institution>Howard Foundation</institution>, <addr-line>Cambridge CB25 ONW</addr-line>,
<country>UK</country></aff><aff id="aff3"><label>3</label><addr-line>Downing College</addr-line>, <institution>University of Cambridge</institution>,
<addr-line>Cambridge CB2 1DQ</addr-line>, <country>UK</country></aff><aff id="aff4"><label>4</label><addr-line>Northern Ireland Centre for Food and Health (NICHE)</addr-line>,
<institution>University of Ulster</institution>, <addr-line>Coleraine BT52
1SA</addr-line>, <country>UK</country></aff><author-notes><corresp id="cor1"><label>*</label><bold>Corresponding author:</bold> Dr D. Kelly, email <email>davidkelly_24@yahoo.co.uk</email></corresp></author-notes><pub-date pub-type="ppub"><day>14</day><month>1</month><year>2017</year></pub-date><volume>117</volume><issue>1</issue><fpage>108</fpage><lpage>123</lpage><history><date date-type="received"><day>05</day><month>7</month><year>2016</year></date><date date-type="rev-recd"><day>30</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>11</day><month>10</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Authors 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>The Authors</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article, distributed under the terms of the Creative
Commons Attribution licence (<uri xlink:type="simple" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted
re-use, distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0007114516003895a.pdf"/><abstract abstract-type="normal"><p>The macular carotenoids lutein (L), zeaxanthin (Z) and <italic>meso</italic>-zeaxanthin
(MZ) accumulate at the macula, where they are collectively referred to as macular pigment
(MP). Augmentation of this pigment, typically achieved through diet and supplementation,
enhances visual function and protects against progression of age-related macular
degeneration. However, it is known that eggs are a rich dietary source of L and Z, in a
highly bioavailable matrix. In this single-blind placebo-controlled study, L- and
MZ-enriched eggs and control non-enriched eggs were fed to human subjects (mean age 41 and
35 years, respectively) over an 8-week period, and outcome measures included MP, visual
function and serum concentrations of carotenoids and cholesterol. Serum carotenoid
concentrations increased significantly in control and enriched egg groups, but to a
significantly greater extent in the enriched egg group (<italic>P</italic>&#x0003c;0&#x000b7;001
for L, Z and MZ). There was no significant increase in MP in either study group post
intervention, and we saw no significant improvement in visual performance in either group.
Total cholesterol increased significantly in each group, but it did not exceed the upper
limit of the normative range (6&#x000b7;5 mmol/l). Therefore, carotenoid-enriched eggs may
represent an effective dietary source of L, Z and MZ, reflected in significantly raised
serum concentrations of these carotenoids, and consequentially improved bioavailability
for capture by target tissues. However, benefits in terms of MP augmentation and /or
improved visual performance were not realised over the 8-week study period, and a study of
greater duration will be required to address these questions.</p></abstract><kwd-group><title>Key words</title><kwd>Lutein</kwd><kwd>Zeaxanthin</kwd><kwd><italic>Meso</italic>-zeaxanthin</kwd><kwd>Macular pigment</kwd><kwd>Carotenoid-enriched eggs</kwd><kwd>Serum carotenoids</kwd><kwd>Cholesterol</kwd></kwd-group><kwd-group kwd-group-type="abbreviations"><title>Abbreviations</title><compound-kwd><compound-kwd-part content-type="abbrev">BCVA</compound-kwd-part><compound-kwd-part content-type="expansion">best-corrected visual
acuity</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">CisZ</compound-kwd-part><compound-kwd-part content-type="expansion"><italic>cis-zeaxanthin</italic></compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">cpd</compound-kwd-part><compound-kwd-part content-type="expansion">cycles per degree</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">CS</compound-kwd-part><compound-kwd-part content-type="expansion">contrast sensitivity</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">EXIT</compound-kwd-part><compound-kwd-part content-type="expansion">Egg Xanthophyll Intervention clinical
Trial</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">L</compound-kwd-part><compound-kwd-part content-type="expansion">lutein</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">MP</compound-kwd-part><compound-kwd-part content-type="expansion">macular pigment</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">MZ</compound-kwd-part><compound-kwd-part content-type="expansion"><italic>meso-zeaxanthin</italic></compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">WIT</compound-kwd-part><compound-kwd-part content-type="expansion">Waterford Institute of
Technology</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">TZ</compound-kwd-part><compound-kwd-part content-type="expansion">total zeaxanthin</compound-kwd-part></compound-kwd><compound-kwd><compound-kwd-part content-type="abbrev">Z</compound-kwd-part><compound-kwd-part content-type="expansion">zeaxanthin</compound-kwd-part></compound-kwd></kwd-group><counts><fig-count count="4"/><table-count count="3"/><page-count count="16"/></counts></article-meta></front><body><p>Lutein (L), zeaxanthin (Z) and <italic>meso</italic>-zeaxanthin (MZ) are oxygenated
xanthophylls belonging to a group of plant pigments known as carotenoids<sup>(</sup>
<xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>)</sup>. These three nutrients accumulate at the back of the human eye, in the central
part of the retina (the macula, a specialised tissue that mediates central vision)<sup>(</sup>
<xref rid="ref2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup>, where they are collectively known as macular pigment (MP). MP has been shown to
protect against progression of age-related macular degeneration (AMD), a disease of the
macula, which is the leading cause of age-related blindness in the developed world<sup>(</sup>
<xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>. This protection conferred upon the macula is achieved through MP&#x02019;s antioxidant
properties, which enable it to quench unstable reactive oxygen species and prevent
consequential damage to the retinal photoreceptors<sup>(</sup>
<xref rid="ref6" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref9" ref-type="bibr">
<sup>9</sup>
</xref>
<sup>)</sup>, and also through its optical light-filtering properties, which facilitate
absorption of high-energy, short-wavelength damaging blue light<sup>(</sup>
<xref rid="ref10" ref-type="bibr">
<sup>10</sup>
</xref>
<sup>,</sup>
<xref rid="ref11" ref-type="bibr">
<sup>11</sup>
</xref>
<sup>)</sup>. MP has also been shown to improve visual function<sup>(</sup>
<xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref>
<sup>)</sup> in both diseased<sup>(</sup>
<xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref>
<sup>)</sup> and non-diseased (healthy)<sup>(</sup>
<xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>)</sup> eyes. We know that in healthy subjects, free of retinal disease (similar to the
subjects recruited into this trial), enrichment of MP following supplementation with a
combination of L, Z and MZ exhibits clinically meaningful improvements in visual
function<sup>(</sup>
<xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref>
<sup>)</sup>. In addition, other <italic>in vivo</italic> murine work has shown that L has the
capacity to both inhibit downstream pathological signals of oxidative stress in the retina and
preserve visual function at the molecular level<sup>(</sup>
<xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>)</sup>. Moreover, in similar <italic>in vivo</italic> work, L was shown to be beneficial
in tight-junction repair in the retina<sup>(</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>)</sup>, whereas human supplementation trials have indicated that L may positively alter
the alternative complement activation pathway by lowering systemic levels of factor D, which
has been found in elevated levels in the blood of AMD patients<sup>(</sup>
<xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref>
<sup>)</sup>.</p><p>Recent studies have also confirmed the presence of L and Z in the non-human primate
brain<sup>(</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup> and the human brain<sup>(</sup>
<xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref27" ref-type="bibr">
<sup>27</sup>
</xref>
<sup>)</sup>, and in concentrations that are proportional to retinal concentrations of these
carotenoids. Interestingly, there is a growing body of evidence that these carotenoids may be
important in maintaining optimal cognitive function<sup>(</sup>
<xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref>
<sup>)</sup>.</p><p>To date, the majority of studies investigating the role of these carotenoids for vision and
cognitive function have relied on the use of commercially available supplement formulations.
Recently, it has been suggested that novel nutrient-enriched (functional) foods may offer an
alternative and a possibly more convenient source of nutrients to consumers, with eggs and
milk being two potential candidates for L, Z and MZ<sup>(</sup>
<xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref37" ref-type="bibr">
<sup>37</sup>
</xref>
<sup>)</sup>.</p><p>Daily intake of L and Z in a typical Western diet is 1&#x02013;3 mg<sup>(</sup>
<xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref>
<sup>)</sup>, with up to 78 % sourced from vegetable intake, such as spinach and kale, and
maize products<sup>(</sup>
<xref rid="ref39" ref-type="bibr">
<sup>39</sup>
</xref>
<sup>,</sup>
<xref rid="ref40" ref-type="bibr">
<sup>40</sup>
</xref>
<sup>)</sup>. In contrast, MZ has only been identified (in trace amounts) in seafood such as
trout, sardines, salmon, shrimp and turtles<sup>(</sup>
<xref rid="ref41" ref-type="bibr">
<sup>41</sup>
</xref>
<sup>,</sup>
<xref rid="ref42" ref-type="bibr">
<sup>42</sup>
</xref>
<sup>)</sup>. Interestingly, and in spite of the lack of dietary MZ, this xanthophyll still
accounts for one-third of total MP<sup>(</sup>
<xref rid="ref43" ref-type="bibr">
<sup>43</sup>
</xref>
<sup>)</sup>, and studies have suggested that MZ is produced by isomerisation of L in the
macula<sup>(</sup>
<xref rid="ref44" ref-type="bibr">
<sup>44</sup>
</xref>
<sup>)</sup>, but this proposed process is poorly understood<sup>(</sup>
<xref rid="ref45" ref-type="bibr">
<sup>45</sup>
</xref>
<sup>)</sup>. Importantly, MZ has been shown to be MP&#x02019;s centrally dominant constituent
carotenoid<sup>(</sup>
<xref rid="ref46" ref-type="bibr">
<sup>46</sup>
</xref>
<sup>)</sup>. In addition, it has been shown (<italic>in vitro</italic>) that MZ exhibits the
greatest antioxidant activity of the three carotenoids, but the combination of all three (L, Z
and MZ) exhibits an even greater antioxidant activity<sup>(</sup>
<xref rid="ref47" ref-type="bibr">
<sup>47</sup>
</xref>
<sup>)</sup>.</p><p>The bioavailability of carotenoids in the diet is determined by the characteristics of the
food matrix in which they are delivered and by possible interactions with other dietary
components<sup>(</sup>
<xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref>
<sup>)</sup>. For example, localisation of L and Z within the chromoplasts of vegetables
reduces their bioavailability to serum when ingested and, accordingly, decreasing the food
particle size (by chopping, blending, pureeing, etc.) and breaking the cell wall (by cooking),
before consumption, is often necessary for optimal absorption<sup>(</sup>
<xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref53" ref-type="bibr">
<sup>53</sup>
</xref>
<sup>)</sup>. Of interest, studies have shown that the bioavailability of the macular
carotenoids may be enhanced when dissolved in a lipid matrix, such as that of the egg yolk,
which contains digestible lipids such as cholesterol, TAG and phospholipids, as this
facilitates efficient digestion and absorption<sup>(</sup>
<xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref>
<sup>)</sup>. Interestingly, several studies have shown that the bioavailability of L and Z
from eggs is superior to that from other food sources and from dietary supplements<sup>(</sup>
<xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref>
<sup>,</sup>
<xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref>
<sup>,</sup>
<xref rid="ref55" ref-type="bibr">
<sup>55</sup>
</xref>
<sup>,</sup>
<xref rid="ref56" ref-type="bibr">
<sup>56</sup>
</xref>
<sup>)</sup>. This is likely because of the presence of HDL found in high concentrations in
eggs, which is known to be the primary transport vehicle for L in the bloodstream<sup>(</sup>
<xref rid="ref57" ref-type="bibr">
<sup>57</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref59" ref-type="bibr">
<sup>59</sup>
</xref>
<sup>)</sup>.</p><p>Hen eggs are produced on an industrial scale, and are consumed as part of a typical diet, and
they provide many nutritional benefits<sup>(</sup>
<xref rid="ref60" ref-type="bibr">
<sup>60</sup>
</xref>
<sup>)</sup>. It has been well documented that supplementation with MP&#x02019;s constituent
carotenoids increases both the serum and retinal concentrations of these nutrients<sup>(</sup>
<xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref>
<sup>,</sup>
<xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>,</sup>
<xref rid="ref61" ref-type="bibr">
<sup>61</sup>
</xref>
<sup>)</sup>, and this has also been demonstrated using carotenoid-rich foods, including
eggs<sup>(</sup>
<xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref>
<sup>,</sup>
<xref rid="ref62" ref-type="bibr">
<sup>62</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref64" ref-type="bibr">
<sup>64</sup>
</xref>
<sup>)</sup>. Accordingly, considering the high HDL content of egg yolks, it is reasonable to
hypothesise that consumption of carotenoid-enriched eggs could offer a unique delivery vehicle
for gastrointestinal absorption and subsequent bioavailability for uptake and capture by
target tissues (including retina and brain). In previous work, we supplemented the feed of
Goldline hens with oil-based L, Z and MZ formulations, which resulted in the production of
macular carotenoid-enriched eggs containing L and MZ in a 1:1 ratio in their yolks<sup>(</sup>
<xref rid="ref65" ref-type="bibr">
<sup>65</sup>
</xref>
<sup>)</sup>.</p><p>In the current study, known as the Egg Xanthophyll Intervention clinical Trial (EXIT), we
report on the outcomes of feeding these eggs to human subjects in terms of serum
concentrations of the macular carotenoids (and cholesterol), MP and visual function.</p><sec sec-type="methods" id="sec1"><title>Methods</title><sec id="sec1-1" sec-type="general"><title>Study design and subjects</title><p>EXIT is a single-blind placebo-controlled 8-week clinical trial that studied the impact
of macular carotenoid-enriched eggs on serum carotenoid concentrations, visual
performance, MP and serum cholesterol levels in human subjects. All subjects signed an
informed consent document, confirming their willingness to participate in the trial.
Ethical approval for the trial was granted by the Ethical Committee of the Waterford
Institute of Technology (WIT), Waterford, Ireland, and the trial also conformed to the
tenets of the Declaration of Helsinki. The EXIT trial was registered on the website <uri xlink:type="simple" xlink:href="http://www.controlled-trials.com">www.controlled-trials.com</uri> (registration number ISRCTN25867083) on the 9th of
August 2013 before participant enrollment. The study was then initiated in September 2013
(first subject study visit) and completed in November 2013 (last subject study visit). For
a graphical summary of the paper, see the CONSORT diagram (online Supplementary material).</p><p>The main outcome measures of the trial were serum carotenoid concentrations, MP, visual
function and serum cholesterol levels.</p><p>Totally, fifty subjects between the ages of 18 and 65 years were recruited into the trial
from the staff of WIT, at two different sites: site 1, the Tourism and Leisure building on
the main WIT campus, and site 2, the Arc Labs building at the WIT west campus. Inclusion
criteria for EXIT included the following: no known allergy to eggs, no history of CVD, no
ocular pathology and cholesterol levels of &#x02264;6&#x000b7;5 mmol/l. In addition, subjects with current
or recent history of supplementation with the macular carotenoids and/or
cholesterol-lowering statins were excluded from the trial. The fifty subjects were divided
equally into two groups of twenty-five.</p><p>For two-tailed tests at the 5 % level of significance, a sample of this size has power of
0&#x000b7;97 to detect an effect size (the size of the mean difference between the two groups) of
0&#x000b7;8 <sc>sd</sc> (of the variable of interest) within groups (paired <italic>t</italic>
test) and a power of 0&#x000b7;79 to detect an effect size of 0&#x000b7;8 <sc>sd</sc> between groups
(independent samples <italic>t</italic> test); the sample does not have sufficient power
to detect smaller effect sizes of, for example, 0&#x000b7;5 <sc>sd</sc>.</p><p>Group 1 was supplemented daily with a standard control (placebo) egg at site 1, on the
main WIT campus, whereas group 2 was given a macular carotenoid-enriched egg (active
intervention), containing L:MZ in a 1:1 ratio at site 2, on the WIT west campus. There was
a 3-km distance between both study sites. Each group was based on a different campus site
to avoid possible &#x02018;contamination&#x02019; of egg samples between the two groups, and also to
preserve the single-blind (masked) nature of the trial, as the macular carotenoid-enriched
eggs had a more pronounced yellow colour than the control eggs, and these colour
differences may have been discerned by participants if mixing of the two groups had been
allowed. Supplementation periods were also staggered between the two groups to accommodate
the completion of final visits within 1 week of ending the supplementation period, as
testing all subjects in 1 week would not be logistically feasible at our research centre.
As a result, participants were not randomly assigned to the two intervention groups.
Vision testing was carried out on all subjects at baseline and final visits, whereas serum
carotenoid and total cholesterol levels were examined at baseline, week 4 and final visit.
Clinical assessments were conducted by J. D., a researcher who was suitably trained on all
aspects of the EXIT protocols.</p></sec><sec id="sec1-2" sec-type="general"><title>Study supplement: carotenoid-enriched hen eggs</title><p>Production of the carotenoid-enriched eggs has been described previously<sup>(</sup>
<xref rid="ref65" ref-type="bibr">
<sup>65</sup>
</xref>
<sup>)</sup>. In brief, 120 Goldline hens, of approximately 20 weeks of age, were divided
into two groups of sixty hens. For the duration of the trial, the hens were housed in a
purpose-built barn on a farm in County Kilkenny in Southern Ireland. This barn was tested
and quality assured by the Food Safety Authority of Ireland, and complied with all health
standards prescribed by the Irish Food Board (BordB&#x000ed;a), including testing for the presence
of salmonella. The first group of hens was fed a standard complete grain feed, without any
additional carotenoids, whereas the second group was given the same standard grain feed as
hens in group 1, but incorporating MZ and L in a 1:1 ratio (70 mg/kg of each), for the
generation of a 140 mg/kg carotenoid-enriched feed. The feed was stored sealed (at room
temperature), to prevent contamination, in 60-kg containers, and fresh feed was provided
daily in the barns hen feeders.</p><p>Supplementation of the hens with the feed began 3 weeks before commencement of subject
supplementation with laid eggs. This was done to allow the eggs to reach their yolk
carotenoid saturation point. Any eggs collected between weeks 1 and 3 of hen
supplementation were hence disposed of as they were not considered suitable as subject
supplement eggs.</p><p>Eggs intended for subject supplementation were collected daily and labelled with group
numbers to avoid cross-contamination between control eggs and carotenoid-enriched eggs.
These eggs were then transported to site 1 and refrigerated at 5&#x000b0;C until they were cooked
for consumption, which took place within 1 week of the egg collection. As a quality check,
four eggs were sampled weekly from both trial groups and tested for yolk carotenoid
concentrations, as described previously<sup>(</sup>
<xref rid="ref65" ref-type="bibr">
<sup>65</sup>
</xref>
<sup>)</sup>.</p><p>With regard to the cooking of the eggs used in the EXIT trial, all eggs were prepared by
one chef, and scrambling was chosen as the cooking method following the assessment of
various cooking options such as boiling, frying and scrambling, as scrambling of the eggs
yielded similar concentrations of carotenoids as the other cooking methods but was
considered more convenient logistically. To ensure reproducibility, a two-egg scrambled
portion was measured using a standardised cup for each individual subject portion. This
cooking method was selected for the comparable dosage that could be achieved between
subjects when the eggs were prepared in batch form, and also for logistical reasons,
namely for the ease of transportation of the group 2 eggs to site 2. This was achieved in
a temperature-controlled &#x02018;hot box&#x02019;, which kept the temperature of the eggs constant
(&#x0003c;10&#x000b0;C drop) during transit. To account for any tedium that may be experienced
because of the necessity for daily consumption of scrambled eggs for an 8-week study
period, different side options were served along with the eggs. Coffee, tea and orange
juice were served with breakfast each day, with toast as a side option on Mondays,
Wednesdays and Fridays, croissants on Tuesdays and English muffins on Thursdays. A study
investigator attended both sites for the duration of the trial to monitor compliance, and
in the event that any subjects were absent two eggs were given to them to take home and
prepare themselves either that day or on a weekend day to account for their day of absence
on site. This ensured that 100 % compliance was achieved with all subjects. Eggs were not
consumed on weekend days (Saturday and Sunday) as a normal part of the trial.</p></sec><sec id="sec1-3" sec-type="general"><title>Macular pigment measurement</title><p>MP was measured at baseline and at final visit (8 weeks) by both customised
heterochromatic flicker photometry using the Macular Densitometer (Macular Metrics
Corp.)<sup>(</sup>
<xref rid="ref66" ref-type="bibr">
<sup>66</sup>
</xref>
<sup>,</sup>
<xref rid="ref67" ref-type="bibr">
<sup>67</sup>
</xref>
<sup>)</sup> and by dual-wavelength autofluorescence using the Spectralis HRA+OCT
Multicolour (Heidelberg Engineering GmbH). Detailed descriptions of the techniques for MP
measurement by both the Densitometer<sup>(</sup>
<xref rid="ref68" ref-type="bibr">
<sup>68</sup>
</xref>
<sup>,</sup>
<xref rid="ref69" ref-type="bibr">
<sup>69</sup>
</xref>
<sup>)</sup> and the Spectralis<sup>(</sup>
<xref rid="ref70" ref-type="bibr">
<sup>70</sup>
</xref>
<sup>,</sup>
<xref rid="ref71" ref-type="bibr">
<sup>71</sup>
</xref>
<sup>)</sup> have been previously reported<sup>(</sup>
<xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref>
<sup>)</sup>. For the purposes of the current clinical trial, MP at 0&#x000b7;25, 0&#x000b7;5 and 1&#x000b7;0&#x000b0; of
retinal eccentricity (Densitometer) and MP at 0&#x000b7;23, 0&#x000b7;51 and 1&#x000b7;02&#x000b0;, in addition to total
MP volume (Spectralis), all with a reference point at 7&#x000b0;, are reported.</p></sec><sec id="sec1-4" sec-type="general"><title>Visual function assessment</title><p>Visual function of the EXIT subjects was assessed by contrast sensitivity (CS) and
best-corrected visual acuity (BCVA). BCVA was measured with a computerised Early Treatment
Diabetic Retinopathy Study (ETDRS) logarithm of the minimum angle of resolution (LogMAR)
test chart (Test Chart 2000 Xpert; Thomson Software Solutions) at a distance of 4 m.
Letter CS was assessed using the computerised LogMAR ETDRS test chart (Test Chart 2000
PRO; Thomson Software Solutions) at five different spatial frequencies (1&#x000b7;2, 2&#x000b7;4, 6&#x000b7;0,
9&#x000b7;6, 15&#x000b7;15 cycles per degree (cpd)). In addition, CS was assessed using the Functional
Vision Analyzer (Stereo Optical Co. Inc.)<sup>(</sup>
<xref rid="ref72" ref-type="bibr">
<sup>72</sup>
</xref>
<sup>)</sup>, which uses the functional acuity contrast test (FACT) at five different
spatial frequencies (1&#x000b7;5, 3, 6, 12, 18 cpd) and under the following light conditions:
mesopic, photopic, mesopic with glare and photopic with glare. Detailed descriptions of
these visual function techniques have been previously described<sup>(</sup>
<xref rid="ref73" ref-type="bibr">
<sup>73</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec1-5" sec-type="general"><title>Serum carotenoid analysis</title><p>Serum L and total zeaxanthin (TZ) (including Z, MZ and <italic>cis</italic>-zeaxanthin
(CisZ)) concentrations were measured at baseline, trial midpoint (4 weeks) and at the
final subject visit (8 weeks). Non-fasting blood samples were collected from study
subjects at each visit, as previously described<sup>(</sup>
<xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref>
<sup>)</sup>, and stored at &#x02212;80&#x000b0;C until the time of analysis. Serum carotenoid
measurements were determined using two separate HPLC assays: assay 1, a reversed-phase
HPLC assay, which quantified both L and TZ concentrations, as previously described<sup>(</sup>
<xref rid="ref74" ref-type="bibr">
<sup>74</sup>
</xref>
<sup>)</sup>, and assay 2, a normal-phase assay, which exploited chiral chromatography to
separate the Z and MZ enantiomers that were collected as a TZ peak in assay 1. A detailed
description of HPLC assay 2 has also been described previously<sup>(</sup>
<xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec1-6" sec-type="general"><title>Egg yolk carotenoid analysis</title><p>Four eggs were removed each week from group 1 and group 2 egg batches and analysed for
their carotenoid content. This was performed to investigate whether carotenoid levels
remained constant in the supplemental eggs over the course of the trial. Preparation of
the egg yolks, extraction of the carotenoids and their analysis by HPLC were performed as
previously described<sup>(</sup>
<xref rid="ref65" ref-type="bibr">
<sup>65</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec1-7" sec-type="general"><title>Serum cholesterol analysis</title><sec id="sec1-7-1" sec-type="general"><title>Total cholesterol</title><p>Total cholesterol was measured using the handheld Roche Accutrend Plus instrument
(Accutrend Cholesterol Cobas<sup>&#x000ae;</sup> system, list number 11418262, 2014; Roche
Diagnostics GmbH) and associated Roche cholesterol test strips (DocCheck; Amtsgericht
Stuttgart), by the classical &#x02018;finger prick&#x02019; method at baseline, trial midpoint
(beginning of week 5) and at the final subject visit (8 weeks). Cholesterol levels were
monitored in the EXIT trial to ensure that no subjects&#x02019; cholesterol level became
elevated &#x0003e;6&#x000b7;5 mmol/l.</p></sec><sec id="sec1-7-2" sec-type="general"><title>Serum HDL-cholesterol</title><p>HDL levels of non-fasting serum samples collected at the EXIT subjects study visits
were measured by Claymon Laboratories Ltd (Biomnis Ireland). HDL-cholesterol was
measured using the Abbott Architect Ultra N-geneous<sup>&#x000ae;</sup> HDL assay
(HDL-cholesterol: Abbott Architect Ultra HDL Instructions for Use, list number 3K33-21,
August 2015; Abbott Laboratories).</p></sec><sec id="sec1-7-3" sec-type="general"><title>Serum LDL-cholesterol</title><p>LDL levels of non-fasting serum samples collected at the EXIT subjects&#x02019; study visits
were measured by Claymon Laboratories Ltd (Biomnis Ireland). LDL-cholesterol was
measured using the MULTIGENT Direct LDL assay (LDL-cholesterol: Abbott Architect Direct
LDL Instructions for Use, list number 1E31-20, August 2015; Abbott Laboratories).</p></sec><sec id="sec1-7-4" sec-type="general"><title>Serum TAG</title><p>Serum TAG levels of non-fasting serum samples collected at the EXIT subjects&#x02019; study
visits were measured by Claymon Laboratories Ltd (Biomnis Ireland). Serum TAG were
measured using the Abbott Architect Triglyceride assay (Triglycerides: Abbott Architect
Triglycerides reagent kit instructions for use, list number 7D74, December 2012; Abbott
Laboratories).</p></sec></sec><sec id="sec1-8" sec-type="general"><title>Statistical analysis</title><p>The statistical package IBM SPSS version 21 was used for all statistical analyses.
Between-group differences (between control and carotenoid-enriched egg groups) at baseline
were investigated using independent-sample <italic>t</italic> or <italic>&#x003c7;</italic>
<sup>2</sup> tests as appropriate, and any variables (such as age or sex) found to be
significantly different between the two groups were controlled for in subsequent analyses.
Changes over time in the primary and secondary outcome measures were analysed using both
paired <italic>t</italic> tests (for within-group changes over time) and general linear
models, the latter controlling for variables found to be significantly different between
groups at baseline. The 5 % significance level was used throughout all analyses, without
any adjustment for multiple tests.</p></sec></sec><sec sec-type="results" id="sec2"><title>Results</title><sec id="sec2-1" sec-type="general"><title>Subject dropouts and adverse events</title><p>Of the fifty subjects originally enrolled in the study, two were removed from the study
at midpoint (4 weeks), as their measured cholesterol concentrations exceeded the
predetermined upper threshold limit of 6&#x000b7;5 mmol/l. Two further subjects also withdrew from
the trial for personal reasons. Therefore, forty-six subjects (twenty-three in each study
group) successfully completed the trial. There were no adverse events reported by subjects
in either study group over the course of the trial.</p></sec><sec id="sec2-2" sec-type="general"><title>Baseline differences between the two study groups</title><p>
<xref ref-type="table" rid="tab1">Table 1</xref> presents the baseline demographic, health
and lifestyle, MP, cholesterol and serum carotenoid data of the control egg group and
carotenoid-enriched egg group subjects in the EXIT clinical trial. As presented in <xref ref-type="table" rid="tab1">Table 1</xref>, the variables for which we found
statistically significant differences between the study groups were age, sex and TAG
levels, and hence we controlled for these in subsequent analyses, where
appropriate.<table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Baseline demographic, health and lifestyle, cholesterol, macular pigment (MP),
visual function and serum carotenoid data of the control group and enriched-group
subjects (Mean values and standard deviations for numerical data and percentages for
categorical data)</p></caption><alternatives><graphic xlink:href="S0007114516003895_tab1"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Control group (<italic>n</italic> 25)</th><th align="center" rowspan="1" colspan="2">Enriched-group (<italic>n</italic>
25)</th><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Sig.</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="char" char="." rowspan="1" colspan="1">41</td><td align="char" char="." rowspan="1" colspan="1">10</td><td align="char" char="." rowspan="1" colspan="1">35</td><td align="char" char="." rowspan="1" colspan="1">8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;015*</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="char" char="." rowspan="1" colspan="1">25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">3&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">25&#x000b7;7</td><td align="char" char="." rowspan="1" colspan="1">3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;478</td></tr><tr><td align="left" rowspan="1" colspan="1">Diet score (estimated L and Z intake)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">20&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">14&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">21&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">9&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;776</td></tr><tr><td align="left" rowspan="1" colspan="1">Exercise (minimum (h)/week)</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">329&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">322&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">219&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">136&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;124</td></tr><tr><td align="left" rowspan="1" colspan="1">Smoking (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;583</td></tr><tr><td align="left" rowspan="1" colspan="1"> Never smoked</td><td align="center" char="." rowspan="1" colspan="2">64</td><td align="center" char="." rowspan="1" colspan="2">68</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Past smoker</td><td align="center" char="." rowspan="1" colspan="2">16</td><td align="center" char="." rowspan="1" colspan="2">20</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Current smoker</td><td align="center" char="." rowspan="1" colspan="2">20</td><td align="center" char="." rowspan="1" colspan="2">12</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Education (highest level %)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;412</td></tr><tr><td align="left" rowspan="1" colspan="1"> Primary</td><td align="center" char="." rowspan="1" colspan="2">4</td><td align="center" char="." rowspan="1" colspan="2">0</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Secondary</td><td align="center" char="." rowspan="1" colspan="2">4</td><td align="center" char="." rowspan="1" colspan="2">4</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Higher (third level)</td><td align="center" char="." rowspan="1" colspan="2">92</td><td align="center" char="." rowspan="1" colspan="2">96</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Sex (%)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;001*</td></tr><tr><td align="left" rowspan="1" colspan="1"> Male</td><td align="center" char="." rowspan="1" colspan="2">40</td><td align="center" char="." rowspan="1" colspan="2">84</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Female</td><td align="center" char="." rowspan="1" colspan="2">60</td><td align="center" char="." rowspan="1" colspan="2">16</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Baseline cholesterol (mmol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> HDL-cholesterol</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;2</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;3</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;119</td></tr><tr><td align="left" rowspan="1" colspan="1"> LDL-cholesterol</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;655</td></tr><tr><td align="left" rowspan="1" colspan="1"> Total cholesterol</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;8</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;5</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;985</td></tr><tr><td align="left" rowspan="1" colspan="1"> TAG</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;1</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;4</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;9</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;018*</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline MP</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Densitometer</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> MP 0&#x000b7;25&#x000b0;</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;527</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;549</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;674</td></tr><tr><td align="left" rowspan="1" colspan="1"> MP 0&#x000b7;5&#x000b0;</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;413</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;16</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;440</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;596</td></tr><tr><td align="left" rowspan="1" colspan="1"> MP 1&#x000b0;</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;283</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;276</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;895</td></tr><tr><td align="left" rowspan="1" colspan="1">Spectralis</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> MP 0&#x000b7;23&#x000b0;</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;475</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;521</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;319</td></tr><tr><td align="left" rowspan="1" colspan="1"> MP 0&#x000b7;51&#x000b0;</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;378</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;11</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;414</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;16</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;369</td></tr><tr><td align="left" rowspan="1" colspan="1"> MP 1&#x000b7;02&#x000b0;</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;271</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;08</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;272</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;981</td></tr><tr><td align="left" rowspan="1" colspan="1"> MP volume</td><td align="char" char="." rowspan="1" colspan="1">5042</td><td align="char" char="." rowspan="1" colspan="1">2054</td><td align="char" char="." rowspan="1" colspan="1">5070</td><td align="char" char="." rowspan="1" colspan="1">2145</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;962</td></tr><tr><td align="left" rowspan="1" colspan="1">BCVA</td><td align="char" char="." rowspan="1" colspan="1">105</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;5</td><td align="left" rowspan="1" colspan="1">106</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;6</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;579</td></tr><tr><td align="left" rowspan="1" colspan="1">CS</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Letter CS 1&#x000b7;2 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;929</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;10</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;924</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;247</td></tr><tr><td align="left" rowspan="1" colspan="1"> Letter CS 2&#x000b7;4 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;984</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;918</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;281</td></tr><tr><td align="left" rowspan="1" colspan="1"> Letter CS 6 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;707</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;651</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;29</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;427</td></tr><tr><td align="left" rowspan="1" colspan="1"> Letter CS 9&#x000b7;6 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;490</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;435</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;31</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;486</td></tr><tr><td align="left" rowspan="1" colspan="1"> Letter CS 15&#x000b7;15 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;114</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;121</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;31</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;932</td></tr><tr><td align="left" rowspan="1" colspan="1"> M FACT CS 1&#x000b7;5 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;756</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;773</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;700</td></tr><tr><td align="left" rowspan="1" colspan="1"> M FACT CS 3 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;881</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;858</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;646</td></tr><tr><td align="left" rowspan="1" colspan="1"> M FACT CS 6 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;660</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;618</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;30</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;592</td></tr><tr><td align="left" rowspan="1" colspan="1"> M FACT CS 12 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;141</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;35</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;214</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;36</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;468</td></tr><tr><td align="left" rowspan="1" colspan="1"> M FACT CS 18 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;540</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;32</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;513</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;28</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;751</td></tr><tr><td align="left" rowspan="1" colspan="1"> P FACT CS 1&#x000b7;5 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;713</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;725</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;797</td></tr><tr><td align="left" rowspan="1" colspan="1"> P FACT CS 3 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;941</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;965</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;597</td></tr><tr><td align="left" rowspan="1" colspan="1"> P FACT CS 6 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;909</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;914</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;935</td></tr><tr><td align="left" rowspan="1" colspan="1"> P FACT CS 12 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;619</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;34</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;590</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;27</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;746</td></tr><tr><td align="left" rowspan="1" colspan="1"> P FACT CS 18 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;906</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;984</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;32</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;434</td></tr><tr><td align="left" rowspan="1" colspan="1"> MG FACT CS 1&#x000b7;5 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;529</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;423</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;27</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;128</td></tr><tr><td align="left" rowspan="1" colspan="1"> MG FACT CS 3 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;665</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;559</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;31</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;165</td></tr><tr><td align="left" rowspan="1" colspan="1"> MG FACT CS 6 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;307</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;32</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;327</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;29</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;818</td></tr><tr><td align="left" rowspan="1" colspan="1"> MG FACT CS 12 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;871</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;31</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;912</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;32</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;650</td></tr><tr><td align="left" rowspan="1" colspan="1"> MG FACT CS 18 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;332</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;11</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;325</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;08</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;801</td></tr><tr><td align="left" rowspan="1" colspan="1"> PG FACT CS 1&#x000b7;5 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;624</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;642</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;699</td></tr><tr><td align="left" rowspan="1" colspan="1"> PG FACT CS 3 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;923</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;923</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;11</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;994</td></tr><tr><td align="left" rowspan="1" colspan="1"> PG FACT CS 6 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;829</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;23</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;860</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;647</td></tr><tr><td align="left" rowspan="1" colspan="1"> PG FACT CS 12 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;515</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;566</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;23</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;569</td></tr><tr><td align="left" rowspan="1" colspan="1"> PG FACT CS 18 cpd</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;906</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;36</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;033</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;150</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline serum carotenoids (&#x000b5;mol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Lutein</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;226</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;188</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;08</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;234</td></tr><tr><td align="left" rowspan="1" colspan="1"> Zeaxanthin</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;079</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;074</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;531</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>cis</italic>-Zeaxanthin</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;024</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;01</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;026</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;01</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;588</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic>meso</italic>-Zeaxanthin</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>Variables, variables analysed in the study; control group, subjects consuming
normal eggs; enriched group, subjects consuming lutein and
<italic>meso</italic>-zeaxanthin enriched eggs; Sig., the statistical difference
(<italic>P</italic> value) between between control and enriched-group subjects
assessed using either independent samples <italic>t</italic> tests or &#x003c7; depending
on the variable of interest; BMI, measure of body fat based on height and weight
(i.e. the body mass divided by the square of the body height); diet score,
estimated dietary intake of lutein and zeaxanthin; exercise, total exercise
measured as minutes per week engaged in physical or sporting activity; smoking
(%), current smoker (smoked &#x02265;100 cigarettes in lifetime and at least one in the
last year), past smoker (smoked &#x02265;100 cigarettes in lifetime and none in the past
year) or non-smoker (smoked &#x0003c;100 cigarettes in lifetime); education
(highest level %), highest level to which the subject was educated; total
cholesterol, measure of HDL, LDL and TAG levels; TAG, fat molecules found in the
blood; esters composed of glycerol and three fatty acids; MP 0&#x000b7;25&#x000b0;, spatial
profile of MP measured at 0&#x000b7;25&#x000b0; of retinal eccentricity with a reference point at
7&#x000b0; (measured using the macular densitometer); MP 0&#x000b7;5&#x000b0;, spatial profile of MP
measured at 0&#x000b7;5&#x000b0; of retinal eccentricity with a reference point at 7&#x000b0; (measured
using the Macular Densitometer<sup>&#x000ae;</sup>); MP 1&#x000b0;, spatial profile of MP measured
at 1&#x000b0; of retinal eccentricity with a reference point at 7&#x000b0; (measured using the
macular densitometer); MP 0&#x000b7;23&#x000b0;, macular pigment optical density at 0&#x000b7;23&#x000b0; of
retinal eccentricity (measured using the Heidelberg Spectralis<sup>&#x000ae;</sup> HRA+OCT
MultiColour); MP 0&#x000b7;51&#x000b0;, macular pigment optical density at 0&#x000b7;51&#x000b0; of retinal
eccentricity (measured using the Heidelberg Spectralis<sup>&#x000ae;</sup> HRA+OCT
MultiColour); MP 1&#x000b7;02&#x000b0;, macular pigment optical density at 1&#x000b7;02&#x000b0; of retinal
eccentricity (measured using the Heidelberg Spectralis<sup>&#x000ae;</sup>); MP volume, a
volume of MP calculated as MP average times the AUC out to 7&#x000b0; eccentricity
(measured using the Heidelberg Spectralis<sup>&#x000ae;</sup>); BCVA, best-corrected
visual acuity reported as visual acuity rating; CS, contrast sensitivity reported
in LogCS; cpd, cycles per degree; M FACT, functional acuity contrast test under
mesopic light conditions; P FACT, functional acuity contrast test under photopic
light conditions; MG FACT, functional acuity contrast test under mesopic with
glare light conditions; PG FACT, functional acuity contrast test under photopic
with glare light conditions; baseline serum carotenoids, serum concentrations of
lutein, zeaxanthin, <italic>cis</italic>-zeaxanthin and
<italic>meso</italic>-zeaxanthin (&#x000b5;mol/l).</p><p>* Statistically significant differences between control and enriched-group
subjects.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="sec2-3" sec-type="general"><title>Within-group changes over time (paired-sample <italic>t</italic> tests)</title><p>The first research question addressed was as follows: which study variables changed
significantly over the 8-week study period? <xref ref-type="table" rid="tab2">Table
2</xref> displays, separately for the intervention and control groups, the results of
paired <italic>t</italic> test analyses for all MP, serum, cholesterol and vision
variables. Statistically significant differences in the table are indicated using
asterisk.<table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Within-group changes over time (paired-sample <italic>t</italic> tests) data for
(a) macular pigment (MP), serum carotenoids (lutein (L), total zeaxanthin (TZ),
<italic>cis</italic>-zeaxanthin (CisZ), zeaxanthin (Z) and
<italic>meso</italic>-zeaxanthin (MZ), cholesterol and TAG (b) contrast sensitivity
(CS) and visual acuity (VA) in the control and enriched egg groups<xref ref-type="fn" rid="tab2fn1">&#x02020;</xref> (Mean values and standard deviations)</p></caption><alternatives><graphic xlink:href="S0007114516003895_tab2"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="2">Baseline visit</th><th align="center" rowspan="1" colspan="2">Final visit</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">Variables and study group</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Diff.</th><th align="center" rowspan="1" colspan="1">Sig.</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="7">
<italic>(a) MP, serum carotenoids (L, TZ, CisZ, Z and MZ), cholesterol and
TAG</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">MP 0&#x000b7;25</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;527</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;542</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;015</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;507</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;554</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;531</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;23</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;022</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;448</td></tr><tr><td align="left" rowspan="1" colspan="1">MP 0&#x000b7;5</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;410</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;437</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;027</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;186</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;446</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;411</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;035</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;244</td></tr><tr><td align="left" rowspan="1" colspan="1">MP 1&#x000b7;0</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;304</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;304</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;000</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;980</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;283</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;228</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;054</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;158</td></tr><tr><td align="left" rowspan="1" colspan="1">MP 0&#x000b7;23</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;470</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;485</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;015</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;250</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;528</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;759</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;16</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;230</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;333</td></tr><tr><td align="left" rowspan="1" colspan="1">MP 0&#x000b7;51</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;378</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;390</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;012</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;279</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;421</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;421</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;000</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;921</td></tr><tr><td align="left" rowspan="1" colspan="1">MP 1&#x000b7;02</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;277</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;09</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;283</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;09</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;006</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;163</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;280</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;279</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;001</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;589</td></tr><tr><td align="left" rowspan="1" colspan="1">MP volume</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5215&#x000b7;91</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2024&#x000b7;46</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5276&#x000b7;09</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2001&#x000b7;63</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">60&#x000b7;182</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;600</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5216&#x000b7;64</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2213&#x000b7;73</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5245&#x000b7;55</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2253&#x000b7;64</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">28&#x000b7;91</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;764</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum L (&#x000b5;mol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;228</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;298</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;070</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;007*</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;195</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;08</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;441</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;246</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x0003c;0&#x000b7;001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum TZ (&#x000b5;mol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;080</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;111</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;031</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;009*</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;074</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;208</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;08</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;134</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x0003c;0&#x000b7;001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum CisZ (&#x000b5;mol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;025</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;01</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;048</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;023</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x0003c;0&#x000b7;001*</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;027</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;01</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;094</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;03</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;067</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x0003c;0&#x000b7;001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum Z (&#x000b5;mol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;080</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;111</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;031</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;009*</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;074</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;02</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;124</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;05</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;050</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x0003c;0&#x000b7;001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum MZ (&#x000b5;mol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="center" rowspan="1" colspan="1">&#x02013;</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;084</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;04</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;084</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x0003c;0&#x000b7;001*</td></tr><tr><td align="left" rowspan="1" colspan="1">Total cholesterol (mmol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;77</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;52</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;63</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;420</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;003*</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;76</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;45</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;981</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;55</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;220</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;025*</td></tr><tr><td align="left" rowspan="1" colspan="1">HDL-cholesterol (mmol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;31</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;27</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;051</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;112</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;29</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;09</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;054</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;065</td></tr><tr><td align="left" rowspan="1" colspan="1">LDL-cholesterol (mmol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;58</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;54</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;62</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;63</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;038</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;664</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;52</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;47</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;59</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;55</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;070</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;444</td></tr><tr><td align="left" rowspan="1" colspan="1">TAG (mmol/l)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;11</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;46</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;69</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;083</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;366</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;61</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;91</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;54</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;72</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;070</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;631</td></tr><tr><td align="left" rowspan="1" colspan="7">
<italic>(b) CS and VA</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Letter CS 1&#x000b7;2 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;045</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;11</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;965</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;080</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;017*</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;970</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;009</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;11</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;039</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;334</td></tr><tr><td align="left" rowspan="1" colspan="1">Letter CS 2&#x000b7;4 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;968</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;968</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;000</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;000</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;966</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;965</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;001</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;971</td></tr><tr><td align="left" rowspan="1" colspan="1">Letter CS 6 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;704</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;684</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;020</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;585</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;697</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;22</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;712</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;015</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;834</td></tr><tr><td align="left" rowspan="1" colspan="1">Letter CS 9&#x000b7;6 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;478</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;22</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;466</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;012</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;801</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;484</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;541</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;057</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;508</td></tr><tr><td align="left" rowspan="1" colspan="1">Letter CS 15&#x000b7;15 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;102</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;095</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;30</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;007</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;830</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;182</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;140</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;23</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;042</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;703</td></tr><tr><td align="left" rowspan="1" colspan="1">M FACT CS 1&#x000b7;5 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;754</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;740</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;013</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;745</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;789</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;743</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;046</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;189</td></tr><tr><td align="left" rowspan="1" colspan="1">M FACT CS 3 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;879</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;22</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;939</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;059</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;186</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;878</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;832</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;28</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;046</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;356</td></tr><tr><td align="left" rowspan="1" colspan="1">M FACT CS 6 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;654</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;26</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;691</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;037</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;489</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;647</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;30</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;658</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;29</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;011</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;851</td></tr><tr><td align="left" rowspan="1" colspan="1">M FACT CS 12 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;138</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;36</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;144</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;36</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;006</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;902</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;238</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;36</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;163</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;32</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;075</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;025*</td></tr><tr><td align="left" rowspan="1" colspan="1">M FACT CS 18 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;548</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;33</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;520</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;29</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;027</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;597</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;519</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;29</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;548</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;31</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;029</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;697</td></tr><tr><td align="left" rowspan="1" colspan="1">P FACT CS 1&#x000b7;5 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;701</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;702</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;008</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;982</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;735</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;722</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;013</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;556</td></tr><tr><td align="left" rowspan="1" colspan="1">P FACT CS 3 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;938</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;18</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;990</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;13</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;052</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;119</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;980</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;09</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;994</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;11</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;014</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;532</td></tr><tr><td align="left" rowspan="1" colspan="1">P FACT CS 6 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;898</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;890</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;42</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;008</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;928</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;935</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;22</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;916</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;019</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;575</td></tr><tr><td align="left" rowspan="1" colspan="1">P FACT CS 12 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;611</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;35</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;669</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;28</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;058</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;205</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;597</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;28</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;717</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;120</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;067</td></tr><tr><td align="left" rowspan="1" colspan="1">P FACT CS 18 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;912</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;997</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;085</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;222</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;995</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;34</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;978</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;36</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;017</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;761</td></tr><tr><td align="left" rowspan="1" colspan="1">MG FACT CS 1&#x000b7;5 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;539</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;501</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;21</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;038</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;372</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;439</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;28</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;539</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;23</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;100</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;047*</td></tr><tr><td align="left" rowspan="1" colspan="1">MG FACT CS 3 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;664</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;22</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;647</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;017</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;646</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;594</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;27</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;637</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;043</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;315</td></tr><tr><td align="left" rowspan="1" colspan="1">MG FACT CS 6 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;302</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;33</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;302</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;38</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;000</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;993</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;343</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;28</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;318</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;32</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;025</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;639</td></tr><tr><td align="left" rowspan="1" colspan="1">MG FACT CS 12 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;895</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;31</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;923</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;35</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;029</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;612</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;934</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;32</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;907</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;28</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;027</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;604</td></tr><tr><td align="left" rowspan="1" colspan="1">MG FACT CS 18 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;335</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;356</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;021</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;328</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;328</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;09</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;342</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;014</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;715</td></tr><tr><td align="left" rowspan="1" colspan="1">PG FACT CS 1&#x000b7;5 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;610</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;14</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;675</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;065</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;066</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;660</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;694</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;19</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;034</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;143</td></tr><tr><td align="left" rowspan="1" colspan="1">PG FACT CS 3 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;912</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;12</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;952</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;17</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;040</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;201</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;932</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;10</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;545</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">2&#x000b7;76</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;612</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;311</td></tr><tr><td align="left" rowspan="1" colspan="1">PG FACT CS 6 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;831</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;898</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;068</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;144</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;888</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;20</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;895</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;007</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;826</td></tr><tr><td align="left" rowspan="1" colspan="1">PG FACT CS 12 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;530</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;37</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;645</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;33</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;115</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;016*</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;585</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;24</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;626</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;25</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;041</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;428</td></tr><tr><td align="left" rowspan="1" colspan="1">PG FACT CS 18 cpd</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;925</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;35</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;928</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;39</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;003</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;949</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;052</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;27</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;047</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;40</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">&#x02212;0&#x000b7;005</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;940</td></tr><tr><td align="left" rowspan="1" colspan="1">BCVA</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"> Control</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">105&#x000b7;217</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;66</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">105&#x000b7;35</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;78</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;130</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;761</td></tr><tr><td align="left" rowspan="1" colspan="1"> Enriched</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">106&#x000b7;227</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">5&#x000b7;15</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">107&#x000b7;73</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">4&#x000b7;45</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">1&#x000b7;50</td><td align="char" char="&#x000b7;" rowspan="1" colspan="1">0&#x000b7;074</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>Variable, variables analysed in the study; control, normal egg study group;
enriched, carotenoid-enriched egg study group; baseline visit, first subject visit
at study initiation; final visit, final subject visit at trial end point (8
weeks); Diff., difference in variable values between the final study visit and the
baseline study visit; Sig., the statistical difference (<italic>P</italic> value)
between the baseline study visit and final study assessed using paired-sample
<italic>t</italic> tests; CS, contrast sensitivity reported in LogCS; cpd,
cycles per degree; M FACT, functional acuity contrast test under mesopic light
conditions; P FACT, functional acuity contrast test under photopic light
conditions; MG FACT, functional acuity contrast test under mesopic with glare
light conditions; PG FACT, functional acuity contrast test under photopic with
glare light conditions; BCVA, best-corrected VA reported as visual acuity rating.</p><p>* Statistically significant differences between baseline and final study
visits.</p></fn><fn id="tab2fn1"><label>&#x02020;</label><p>Data displayed are the results of paired <italic>t</italic> test analyses.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="sec2-4" sec-type="general"><title>Between-group changes over time (repeated measures)</title><p>The second research question addressed was as follows: which study variables changed
significantly more in the enriched egg group compared with the control group?
Repeated-measures ANOVA was used in this part of the study, to compare change in these
variables between intervention and control groups. These analyses controlled for baseline
age, TAG (except when the outcome variable was cholesterol related) and sex, all of which
were significantly different between intervention and control groups at baseline. Results
from analyses, within-group and between-group, are presented (below) for each outcome
variable. <xref ref-type="fig" rid="fig1">Fig. 1</xref>&#x02013;<xref ref-type="fig" rid="fig4">4</xref> graphically illustrate the observed statistically significant between-group
changes in outcome variables over the 8-week study period.<fig id="fig1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Change in letter contrast sensitivity (CS) values between baseline and final visit
(8 weeks) and at five different spatial frequencies: 1&#x000b7;20, 2&#x000b7;40, 6&#x000b7;00, 9&#x000b7;60 and
15&#x000b7;15 cycles per degree (cpd) using the Test Chart 2000 PRO<sup>TM</sup> (Thomson
Software Solutions) in the Egg Xanthophyll Intervention Trial; control egg group
subjects; one standard egg per day. Enriched egg group subjects; one
lutein:<italic>meso</italic>-zeaxanthin enriched egg per day. An improvement in CS
at final visit in the enriched egg group relative to the control group is seen at
15&#x000b7;15 cpd reflected in the higher LogCS value. Values are means, with their standard
errors. <inline-graphic xlink:href="S0007114516003895_inline1.jpg" mime-subtype="gif"/>, Baseline visit; <inline-graphic xlink:href="S0007114516003895_inline2.jpg" mime-subtype="gif"/>,
8-week visit.</p></caption><graphic xlink:href="S0007114516003895_fig1"/></fig>
<fig id="fig2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Change in best corrected visual acuity (BCVA) rating values between baseline and
final visit (8 weeks) measured with Test Chart 2000 Xpert (Thomson Software
Solutions) in the Egg Xanthophyll Intervention Trial; control egg group subjects
(<inline-graphic xlink:href="S0007114516003895_inline3.jpg" mime-subtype="gif"/>); one standard egg per day. Enriched egg
group subjects (<inline-graphic xlink:href="S0007114516003895_inline4.jpg" mime-subtype="gif"/>); one
lutein:<italic>meso</italic>-zeaxanthin enriched egg per day. An improvement in BCVA
at final visit in the enriched egg group relative to the control group is reflected
in the higher visual acuity rating (VAR).</p></caption><graphic xlink:href="S0007114516003895_fig2"/></fig>
<fig id="fig3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Change in serum concentrations (&#x000b5;mol/l) of lutein (L), total zeaxanthin (TZ),
<italic>cis</italic>-zeaxanthin (CisZ), <italic>meso</italic>-zeaxanthin (MZ) and
zeaxanthin (Z) between baseline, midpoint (4 weeks) and final visit (8 weeks) using
both reversed phase HPLC for L, TZ and CisZ analysis, and normal phase HPLC for Z:MZ
ratio analysis on an Agilent 1260 Series system (Agilent Technologies Limited) in
the Egg Xanthophyll Intervention Trial; control egg group subjects (<inline-graphic xlink:href="S0007114516003895_inline5.jpg" mime-subtype="gif"/>);
one standard egg per day. Enriched egg group subjects (<inline-graphic xlink:href="S0007114516003895_inline6.jpg" mime-subtype="gif"/>);
one L:MZ enriched egg per day. Increases in serum carotenoid levels can be seen at
midpoint and final visits in the enriched egg group relative to the control group
for L, TZ, CisZ and MZ, which are reflected in the higher concentration values seen.
Increases in serum Z levels can be seen at midpoint in the enriched egg group
relative to the control group, which are reflected in the higher concentration
values seen. However, concentrations of Z were not significantly different between
groups at final visit, reflected in the similarity of serum Z concentrations in both
groups. Values are means, with their standard errors.</p></caption><graphic xlink:href="S0007114516003895_fig3"/></fig>
<fig id="fig4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Weekly analysis of egg yolk concentrations (&#x000b5;g/yolk) of lutein (L), total
zeaxanthin (TZ), <italic>cis</italic>-zeaxanthin (CisZ) and
<italic>meso</italic>-zeaxanthin (MZ) over a 7-week period using both reversed phase
HPLC for L, TZ and CisZ analysis, and normal phase HPLC for MZ analysis on an
Agilent 1260 Series system (Agilent Technologies Limited) in the Egg Xanthophyll
Intervention Trial. Week-to-week variation can be seen by analysis of the trend in
concentration values of both the control (<inline-graphic xlink:href="S0007114516003895_inline7.jpg" mime-subtype="gif"/>) and enriched
(<inline-graphic xlink:href="S0007114516003895_inline8.jpg" mime-subtype="gif"/>) eggs.</p></caption><graphic xlink:href="S0007114516003895_fig4"/></fig>
</p></sec><sec id="sec2-5" sec-type="general"><title>Macular pigment measurement</title><p>MP was measured at baseline and at the final study visit (8 weeks) for both subject
groups. As presented in <xref ref-type="table" rid="tab2">Table 2</xref>, we found no
significant MP response to egg supplementation in either the control group or the enriched
egg group over the 8-week study period, nor were there significant between-group
differences in MP at any measured eccentricities, whether measured on the Densitometer (MP
0&#x000b7;25; <italic>P</italic>=0&#x000b7;840, MP 0&#x000b7;5; <italic>P</italic>=0&#x000b7;593, MP 1&#x000b7;0;
<italic>P</italic>=0&#x000b7;579) or Spectralis (MP 0&#x000b7;23; <italic>P</italic>=0&#x000b7;706, MP 0&#x000b7;51;
<italic>P</italic>=0&#x000b7;663, MP 1&#x000b7;02; <italic>P</italic>=0&#x000b7;345, MP volume;
<italic>P</italic>=0&#x000b7;979).</p></sec><sec id="sec2-6" sec-type="general"><title>Contrast sensitivity and best-corrected visual acuity</title><p>CS was measured at baseline and at the final study visit (8 weeks) for both subject
groups. In relation to the within-group changes over the 8-week study period, presented in
<xref ref-type="table" rid="tab3">Table 2</xref>, we noted a significant decrease in the
control group for letter CS at 1&#x000b7;2 cpd (<italic>P</italic>=0&#x000b7;017) and a significant
increase in FACT CS at 12 cpd under photopic conditions with glare
(<italic>P</italic>=0&#x000b7;016). In the enriched egg group, there was a significant decrease in
FACT CS at 12 cpd under mesopic conditions (<italic>P</italic>=0&#x000b7;025), and a significant
increase in FACT CS at 1&#x000b7;5 cpd under mesopic conditions with glare
(<italic>P</italic>=0&#x000b7;047).</p><p>Controlling for age, sex and TAG using the general linear model repeated measures test,
we noted only one between-group difference over the course of the study for measures of
visual function, as presented in <xref ref-type="fig" rid="fig1">Fig. 1</xref>. This was
for the letter CS at 15&#x000b7;15 cpd (<italic>P</italic>=0&#x000b7;046), which exhibited an improvement
in the enriched egg group.</p><p>BCVA was measured at baseline and at the final study visit (8 weeks) for both subject
groups. As presented in <xref ref-type="table" rid="tab3">Table 2</xref>, there was no
significant change in BCVA in either the control (<italic>P</italic>=0&#x000b7;761) or enriched
(<italic>P</italic>=0&#x000b7;074) egg groups over the course of the study. However, we did note
a statistically significant between-group difference (<italic>P</italic>=0&#x000b7;035) after
controlling for age, sex and TAG using the general linear model repeated-measures test,
because of a small improvement in BCVA in the enriched egg group and a small decrease in
the control group (see <xref ref-type="fig" rid="fig2">Fig. 2</xref>).</p></sec><sec id="sec2-7" sec-type="general"><title>Serum carotenoid analysis</title><p>Serum carotenoid concentrations were measured at baseline, trial midpoint (4 weeks) and
at the final subject visit (8 weeks). As presented in <xref ref-type="table" rid="tab2">Table 2</xref>, serum L, TZ, Z and CisZ concentrations increased significantly over
time in both the control (<italic>P</italic>=0&#x000b7;007, 0&#x000b7;009, 0&#x000b7;009 and &#x0003c;0&#x000b7;001,
respectively) and enriched (<italic>P</italic>&#x0003c;0&#x000b7;001 for all) egg groups, whereas
serum MZ concentration increased significantly only in the enriched egg group
(<italic>P</italic>&#x0003c;0&#x000b7;001). In terms of between-group differences, controlling for
age, sex and TAG using the general linear model repeated measures test, the enriched egg
group showed a significantly greater serum response to L, TZ, CisZ and MZ
(<italic>P&#x0003c;</italic>0&#x000b7;001 for all) than the control group. Both study groups were
found to respond comparably with respect to Z, with no significant between-group
difference noted after 8 weeks (<italic>P</italic>=0&#x000b7;477) (see <xref ref-type="fig" rid="fig3">Fig. 3</xref>).</p></sec><sec id="sec2-8" sec-type="general"><title>Egg yolk carotenoid analysis</title><p>Four eggs were taken weekly from the batch of study eggs of both normal and enriched egg
groups and tested for their carotenoid content for the duration of the EXIT study. These
results are presented in <xref ref-type="fig" rid="fig4">Fig. 4</xref>. Week-to-week
variation in yolk L concentrations was not statistically significant over the course of
the trial in either the control (<italic>P</italic>=0&#x000b7;258) or enriched
(<italic>P</italic>=0&#x000b7;126) egg groups (<italic>P</italic> values quoted are from ANOVA).
However, there was significant week-to-week variation in yolk Z
(<italic>P</italic>=0&#x000b7;032), CisZ (<italic>P</italic>=0&#x000b7;010) and MZ
(<italic>P</italic>=0&#x000b7;005) concentrations in the enriched egg group.</p></sec><sec id="sec2-9" sec-type="general"><title>Serum cholesterol analysis</title><p>Total cholesterol, HDL-cholesterol and TAG levels were measured at baseline, midpoint (4
weeks) and final study visit (8 weeks) for both subject groups. As presented in <xref ref-type="table" rid="tab2">Table 2</xref>, total cholesterol levels increased
significantly within both the control (<italic>P</italic>=0&#x000b7;003) and enriched
(<italic>P</italic>=0&#x000b7;025) egg groups over the course of the study. However, we saw no
statistically significant between-group differences for total cholesterol
(<italic>P</italic>=0&#x000b7;561). Similarly, as presented in <xref ref-type="table" rid="tab2">Table 2</xref>, we report no significant increase (<italic>P</italic>&#x0003e;0&#x000b7;05 for
all), either within treatment groups or between treatment groups, in terms of
HDL-cholesterol, LDL-cholesterol or TAG levels over the course of the trial.</p></sec></sec><sec sec-type="discussion" id="sec3"><title>Discussion</title><p>This study presents findings of the EXIT, a clinical trial designed to study the impact of
the consumption of normal (control) eggs, and carotenoid (L and MZ)-enriched eggs on serum
carotenoid concentrations, visual performance and MP densities in human subjects. As a
secondary outcome measure, serum cholesterol levels were also monitored in both study groups
over the course of the trial. The rationale and motivation for undertaking the current study
relates to the suggested role that the yolk matrix, which is liquid in nature and of high
lipoprotein content, may play in enhancing carotenoid absorption and, therefore,
bioavailability of these compounds in humans<sup>(</sup>
<xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref>
<sup>,</sup>
<xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref>
<sup>)</sup>. Indeed, the potential of eggs to enhance carotenoid serum responses, when
compared with other foods and supplements, has been suggested by the findings of previous
studies<sup>(</sup>
<xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref>
<sup>,</sup>
<xref rid="ref55" ref-type="bibr">
<sup>55</sup>
</xref>
<sup>,</sup>
<xref rid="ref56" ref-type="bibr">
<sup>56</sup>
</xref>
<sup>)</sup>. It is worth noting that previous studies have investigated the consumption of
both L<sup>(</sup>
<xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref>
<sup>,</sup>
<xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref>
<sup>,</sup>
<xref rid="ref55" ref-type="bibr">
<sup>55</sup>
</xref>
<sup>,</sup>
<xref rid="ref59" ref-type="bibr">
<sup>59</sup>
</xref>
<sup>,</sup>
<xref rid="ref63" ref-type="bibr">
<sup>63</sup>
</xref>
<sup>,</sup>
<xref rid="ref75" ref-type="bibr">
<sup>75</sup>
</xref>
<sup>)</sup>- and Z<sup>(</sup>
<xref rid="ref62" ref-type="bibr">
<sup>62</sup>
</xref>
<sup>,</sup>
<xref rid="ref76" ref-type="bibr">
<sup>76</sup>
</xref>
<sup>)</sup>-enriched eggs and their effect on MP, vision and serum concentrations of the
carotenoids. In addition, there was also one study that investigated the serum response to
MZ-enriched eggs<sup>(</sup>
<xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref>
<sup>)</sup>. However, the current investigation is the first to report on the serum, MP and
visual response to eggs enriched with L and MZ.</p><p>The main finding from this study was that there was a statistically significant increase in
serum carotenoid concentrations in the control and enriched egg groups over the course of
the trial, whereas no significant MP changes were seen in either study group. In relation to
visual performance, although we noted some significant trends for both CS and VA
measurements (in terms of some significant, but not clinically meaningful, improvements in
the enriched egg group), overall, consumption of both the control and enriched eggs over the
study period appeared to show no significant effects on subject&#x02019;s visual performance. A
significant increase in total cholesterol was noted in both control and enriched egg groups
over the course of the trial; however, no significant changes in serum HDL and LDL or TAG
levels were evident.</p><p>In relation to serum carotenoid changes in this study, it was perhaps not surprising that
we saw a response in both the control and enriched egg study groups, as hen eggs are known
to be naturally bioavailable sources of both L and Z because of the colocalisation of these
xanthophylls with egg yolk HDL<sup>(</sup>
<xref rid="ref59" ref-type="bibr">
<sup>59</sup>
</xref>
<sup>,</sup>
<xref rid="ref60" ref-type="bibr">
<sup>60</sup>
</xref>
<sup>,</sup>
<xref rid="ref75" ref-type="bibr">
<sup>75</sup>
</xref>
<sup>)</sup>. The enriched eggs used in this study induced a response in terms of serum L
concentrations that was significantly greater than that seen among subjects supplemented
with normal control eggs (increases of 126 and 31 %, respectively). The serum Z response was
also greater (but not significantly so) in the enriched egg group when compared with the
control group (68 and 39 % increases, respectively). These results are comparable with
most<sup>(</sup>
<xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref>
<sup>,</sup>
<xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref>
<sup>,</sup>
<xref rid="ref63" ref-type="bibr">
<sup>63</sup>
</xref>
<sup>,</sup>
<xref rid="ref75" ref-type="bibr">
<sup>75</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref78" ref-type="bibr">
<sup>78</sup>
</xref>
<sup>)</sup>, but not all<sup>(</sup>
<xref rid="ref62" ref-type="bibr">
<sup>62</sup>
</xref>
<sup>,</sup>
<xref rid="ref79" ref-type="bibr">
<sup>79</sup>
</xref>
<sup>,</sup>
<xref rid="ref80" ref-type="bibr">
<sup>80</sup>
</xref>
<sup>)</sup>, previous reports (<xref ref-type="table" rid="tab3">Table 3</xref>). The
finding by Wenzel <italic>et al</italic>.<sup>(</sup>
<xref rid="ref62" ref-type="bibr">
<sup>62</sup>
</xref>
<sup>)</sup> that serum Z, but not serum L, increased following 12 weeks&#x02019; supplementation
could perhaps be considered unusual, as most studies (including the current one) demonstrate
a clear increase in serum L concentrations following egg intervention. It is perhaps worth
noting, however, that a more significant increase in serum Z was indeed noted in many
studies when compared with that of serum L<sup>(</sup>
<xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref>
<sup>,</sup>
<xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref>
<sup>,</sup>
<xref rid="ref63" ref-type="bibr">
<sup>63</sup>
</xref>
<sup>,</sup>
<xref rid="ref75" ref-type="bibr">
<sup>75</sup>
</xref>
<sup>,</sup>
<xref rid="ref76" ref-type="bibr">
<sup>76</sup>
</xref>
<sup>)</sup>. A possible contributory factor may be the effect of cooking of the eggs, as
cooking-mediated losses of L have been reported to be greater than those of Z<sup>(</sup>
<xref rid="ref81" ref-type="bibr">
<sup>81</sup>
</xref>
<sup>)</sup>. Thurnham<sup>(</sup>
<xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref>
<sup>)</sup> has reported that observed increases in plasma Z concentrations can be a
function of lower baseline Z concentrations in comparison with baseline L concentrations,
thereby favouring more marked rises in serum concentrations of Z.<table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Studies presenting the serum carotenoid and macular pigment (MP) response to egg
supplementation</p></caption><alternatives><graphic xlink:href="S0007114516003895_tab3"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1">Study</th><th align="center" rowspan="1" colspan="1">Year</th><th align="center" rowspan="1" colspan="1">
<italic>n</italic>
</th><th align="left" rowspan="1" colspan="1">Sex</th><th align="center" rowspan="1" colspan="1">Age (years)</th><th align="left" rowspan="1" colspan="1">Study duration</th><th align="left" rowspan="1" colspan="1">Intervention</th><th align="left" rowspan="1" colspan="1">L response</th><th align="left" rowspan="1" colspan="1">Z response</th><th align="left" rowspan="1" colspan="1">MP response</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Handelman <italic>et al</italic>.<sup>(</sup>
<xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref>
<sup>)</sup>
</td><td align="char" char="." rowspan="1" colspan="1">1999</td><td align="char" char="." rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">6m, 5f</td><td align="char" char="&#x02013;" rowspan="1" colspan="1">46&#x02013;78</td><td align="left" rowspan="1" colspan="1">4&#x000b7;5 weeks/diet</td><td align="left" rowspan="1" colspan="1">G1: maize oil</td><td align="left" rowspan="1" colspan="1">G1: no response</td><td align="left" rowspan="1" colspan="1">G1: no response</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(washout period of &#x02265;2 weeks between
diets)</td><td align="left" rowspan="1" colspan="1">G2: beef tallow</td><td align="left" rowspan="1" colspan="1">G2: no response</td><td align="left" rowspan="1" colspan="1">G2: no response</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G3: maize oil+1&#x000b7;3 egg yolks daily</td><td align="left" rowspan="1" colspan="1">G3: 50 % increase relative to G1</td><td align="left" rowspan="1" colspan="1">G3: 114 % increase relative to G1</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G4: beef tallow+1&#x000b7;3 egg yolks daily</td><td align="left" rowspan="1" colspan="1">G4: 28 % increase relative to G2</td><td align="left" rowspan="1" colspan="1">G4: 142 % increase relative to G2</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Goodrow <italic>et al</italic>.<sup>(</sup>
<xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref>
<sup>)</sup>
</td><td align="char" char="." rowspan="1" colspan="1">2006</td><td align="char" char="." rowspan="1" colspan="1">33</td><td align="left" rowspan="1" colspan="1">7m, 26f</td><td align="char" char="&#x02013;" rowspan="1" colspan="1">60&#x02013;96</td><td align="left" rowspan="1" colspan="1">8 weeks</td><td align="left" rowspan="1" colspan="1">One egg daily</td><td align="left" rowspan="1" colspan="1">26 % increase</td><td align="left" rowspan="1" colspan="1">38 % increase</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Wenzel <italic>et al</italic>.<sup>(</sup>
<xref rid="ref62" ref-type="bibr">
<sup>62</sup>
</xref>
<sup>)</sup>
</td><td align="char" char="." rowspan="1" colspan="1">2006</td><td align="char" char="." rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">0m, 24f</td><td align="char" char="&#x02013;" rowspan="1" colspan="1">24&#x02013;59</td><td align="left" rowspan="1" colspan="1">12 weeks</td><td align="left" rowspan="1" colspan="1">6 (L and Z in combination) enriched eggs
weekly</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Sig. increase in both treatment groups,
in a linear manner from 4 to 8 weeks, to 12 weeks</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G1: 331 &#x000b5;g combination</td><td align="left" rowspan="1" colspan="1">G1: no sig response</td><td align="left" rowspan="1" colspan="1">G1: 50 % increase</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G2: 946 &#x000b5;g combination</td><td align="left" rowspan="1" colspan="1">G2: no sig response</td><td align="left" rowspan="1" colspan="1">G2: 82 % increase</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Vishwanathan <italic>et
al</italic>.(<sup>63</sup>)</td><td align="char" char="." rowspan="1" colspan="1">2009</td><td align="char" char="." rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1">21m, 31f</td><td align="center" rowspan="1" colspan="1">&#x02265;60</td><td align="left" rowspan="1" colspan="1">5 weeks/phase</td><td align="left" rowspan="1" colspan="1">G1: 2 egg yolks daily</td><td align="left" rowspan="1" colspan="1">G1: 16 % increase</td><td align="left" rowspan="1" colspan="1">G1: 24 % increase</td><td align="left" rowspan="1" colspan="1">Changes in MP were inversely related to
baseline MP levels</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">(4-week egg-free period between phases)</td><td align="left" rowspan="1" colspan="1">G2: 4 egg yolks daily</td><td align="left" rowspan="1" colspan="1">G2: 36 % increase</td><td align="left" rowspan="1" colspan="1">G2: 82 % increase</td><td align="left" rowspan="1" colspan="1">G1: 30 % increase at 0&#x000b7;5&#x000b0;
eccentricity</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G2: &#x02264;50 % increase at 0&#x000b7;25, 0&#x000b7;5 and 1&#x000b0;
eccentricity</td></tr><tr><td align="left" rowspan="1" colspan="1">van der Made <italic>et
al</italic>.<sup>(</sup>
<xref rid="ref64" ref-type="bibr">
<sup>64</sup>
</xref>
<sup>)</sup>
</td><td align="char" char="." rowspan="1" colspan="1">2016</td><td align="char" char="." rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">32m, 68f</td><td align="char" char="&#x02013;" rowspan="1" colspan="1">62&#x02013;63</td><td align="left" rowspan="1" colspan="1">1 year</td><td align="left" rowspan="1" colspan="1">G1: egg-yolk-free buttermilk drink daily
G2: 1&#x000b7;5 egg yolk buttermilk drink enriched with L, Z and DHA daily</td><td align="left" rowspan="1" colspan="1">G1: no sig response G2: 94 % increase</td><td align="left" rowspan="1" colspan="1">G1: no sig response G2: similar increase
to L</td><td align="left" rowspan="1" colspan="1">G1: no sig response G2: sig. increase in
L group relative to control group, and also within L group in comparison with
baseline</td></tr><tr><td align="left" rowspan="1" colspan="1">Blesso <italic>et al</italic>.<sup>(</sup>
<xref rid="ref75" ref-type="bibr">
<sup>75</sup>
</xref>
<sup>)</sup>
</td><td align="char" char="." rowspan="1" colspan="1">2013</td><td align="char" char="." rowspan="1" colspan="1">37</td><td align="left" rowspan="1" colspan="1">12m, 25f</td><td align="char" char="&#x02013;" rowspan="1" colspan="1">30&#x02013;70</td><td align="left" rowspan="1" colspan="1">12 weeks</td><td align="left" rowspan="1" colspan="1">G1: egg-yolk-free substitute daily</td><td align="left" rowspan="1" colspan="1">G1: no sig response</td><td align="left" rowspan="1" colspan="1">G1: no sig response</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G2: 3 whole eggs daily</td><td align="left" rowspan="1" colspan="1">G2: 21 % increase</td><td align="left" rowspan="1" colspan="1">G2: 48 % increase</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Kelly <italic>et al</italic>.<sup>(</sup>
<xref rid="ref76" ref-type="bibr">
<sup>76</sup>
</xref>
<sup>)</sup>
</td><td align="char" char="." rowspan="1" colspan="1">2014</td><td align="char" char="." rowspan="1" colspan="1">100</td><td align="left" rowspan="1" colspan="1">43m, 57f</td><td align="center" rowspan="1" colspan="1">&#x02265;18</td><td align="left" rowspan="1" colspan="1">90 d</td><td align="left" rowspan="1" colspan="1">G1: unmodified diet</td><td align="left" rowspan="1" colspan="1">G1: no sig response</td><td align="left" rowspan="1" colspan="1">G1: no sig response</td><td align="left" rowspan="1" colspan="1">No sig response</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G2: 1 normal egg daily</td><td align="left" rowspan="1" colspan="1">G2: no sig response</td><td align="left" rowspan="1" colspan="1">G2: no sig response</td><td align="left" rowspan="1" colspan="1">No sig response</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G3: 1 L-enriched egg daily</td><td align="left" rowspan="1" colspan="1">G3: 76 % increase</td><td align="left" rowspan="1" colspan="1">G3: no sig response</td><td align="left" rowspan="1" colspan="1">No sig response</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G4: 1 Z-enriched egg daily</td><td align="left" rowspan="1" colspan="1">G4: no sig response</td><td align="left" rowspan="1" colspan="1">G4: 430 % increase</td><td align="left" rowspan="1" colspan="1">No sig response</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G5: 1 L-enriched egg yolk beverage daily</td><td align="left" rowspan="1" colspan="1">G5: 77 % increase</td><td align="left" rowspan="1" colspan="1">G5: no sig response</td><td align="left" rowspan="1" colspan="1">No sig response</td></tr><tr><td align="left" rowspan="1" colspan="1">Mutungi <italic>et al</italic>.<sup>(</sup>
<xref rid="ref77" ref-type="bibr">
<sup>77</sup>
</xref>
<sup>)</sup>
</td><td align="char" char="." rowspan="1" colspan="1">2010</td><td align="char" char="." rowspan="1" colspan="1">31</td><td align="left" rowspan="1" colspan="1">31m, 0f</td><td align="char" char="&#x02013;" rowspan="1" colspan="1">40&#x02013;70</td><td align="left" rowspan="1" colspan="1">12 weeks</td><td align="left" rowspan="1" colspan="1">G1: egg-yolk-free substitute daily</td><td align="left" rowspan="1" colspan="1">G1: &#x02013;</td><td align="left" rowspan="1" colspan="1">G1: 40 % decrease</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G2: 3 liquid eggs daily</td><td align="left" rowspan="1" colspan="1">G2: 80 % increase</td><td align="left" rowspan="1" colspan="1">G2: 40 % increase</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">van der Made <italic>et
al</italic>.<sup>(</sup>
<xref rid="ref78" ref-type="bibr">
<sup>78</sup>
</xref>
<sup>)</sup>
</td><td align="char" char="." rowspan="1" colspan="1">2014</td><td align="char" char="." rowspan="1" colspan="1">89</td><td align="left" rowspan="1" colspan="1">29m, 60f</td><td align="center" rowspan="1" colspan="1">&#x02265;50</td><td align="left" rowspan="1" colspan="1">1 year</td><td align="left" rowspan="1" colspan="1">G1: egg-yolk-free buttermilk beverage
daily</td><td align="left" rowspan="1" colspan="1">G1: no sig response</td><td align="left" rowspan="1" colspan="1">G1: no sig response</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G2: 1&#x000b7;5 egg yolk L-enriched buttermilk
beverage daily</td><td align="left" rowspan="1" colspan="1">G2: 83 % increase relative to G1</td><td align="left" rowspan="1" colspan="1">G2: 110 % increase relative to G1</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Surai <italic>et al</italic>.<sup>(</sup>
<xref rid="ref79" ref-type="bibr">
<sup>79</sup>
</xref>
<sup>)</sup>
</td><td align="char" char="." rowspan="1" colspan="1">2000</td><td align="char" char="." rowspan="1" colspan="1">44</td><td align="left" rowspan="1" colspan="1">24m, 20f</td><td align="char" char="&#x02013;" rowspan="1" colspan="1">26&#x02013;59</td><td align="left" rowspan="1" colspan="1">8 weeks</td><td align="left" rowspan="1" colspan="1">G1: 1 normal egg daily</td><td align="left" rowspan="1" colspan="1">G1: no sig response</td><td align="left" rowspan="1" colspan="1">G1: no sig response</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G2: 1 L-enriched egg daily</td><td align="left" rowspan="1" colspan="1">G2: 1&#x000b7;88-fold increase relative to G1</td><td align="left" rowspan="1" colspan="1">G2: no sig response</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Bunger <italic>et al</italic>.<sup>(</sup>
<xref rid="ref80" ref-type="bibr">
<sup>80</sup>
</xref>
<sup>)</sup>
</td><td align="char" char="." rowspan="1" colspan="1">2014</td><td align="char" char="." rowspan="1" colspan="1">94</td><td align="left" rowspan="1" colspan="1">21m, 73f</td><td align="char" char="&#x02013;" rowspan="1" colspan="1">18&#x02013;35</td><td align="left" rowspan="1" colspan="1">6 weeks</td><td align="left" rowspan="1" colspan="1">G1: L-free 1&#x000b7;5 egg yolk buttermilk
beverage</td><td align="left" rowspan="1" colspan="1">G1: 11&#x000b7;8 % decrease</td><td align="left" rowspan="1" colspan="1">G1: 18 % decrease</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G2: fresh L-enriched 1&#x000b7;5 egg yolk
buttermilk beverage</td><td align="left" rowspan="1" colspan="1">G2: 107 % increase</td><td align="left" rowspan="1" colspan="1">G2: 55&#x000b7;1 % increase</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G3: dried version of G2 beverage
suspended in water</td><td align="left" rowspan="1" colspan="1">G3: 51&#x000b7;2 % increase</td><td align="left" rowspan="1" colspan="1">G3: 48&#x000b7;1 % increase</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G4: dried individual components of G2
beverage suspended in water</td><td align="left" rowspan="1" colspan="1">G4: 70&#x000b7;9 % increase</td><td align="left" rowspan="1" colspan="1">G4: 56&#x000b7;8 % increase</td><td align="center" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">EXIT study: Kelly <italic>et
al</italic>.<xref ref-type="fn" rid="tab3fn1">*</xref>
</td><td align="char" char="." rowspan="1" colspan="1">2016</td><td align="char" char="." rowspan="1" colspan="1">50</td><td align="left" rowspan="1" colspan="1">31m, 19f</td><td align="char" char="&#x02013;" rowspan="1" colspan="1">18&#x02013;65</td><td align="left" rowspan="1" colspan="1">8 weeks</td><td align="left" rowspan="1" colspan="1">G1: 2 scrambled eggs daily</td><td align="left" rowspan="1" colspan="1">G1: 31 % increase</td><td align="left" rowspan="1" colspan="1">G1: 39 % increase</td><td align="left" rowspan="1" colspan="1">No sig response</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">G2: 2L and MZ-enriched scrambled eggs
daily</td><td align="left" rowspan="1" colspan="1">G2: 126 % increase</td><td align="left" rowspan="1" colspan="1">G2: 68 % increase</td><td align="left" rowspan="1" colspan="1">No sig response</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>
<italic>n</italic>, Number of subjects; m, male; f, female; L, lutein; Z,
zeaxanthin; &#x02013;, not measured; G, study group; sig, significant; EXIT, Egg Xanthophyll
Intervention Trial; MZ, <italic>meso</italic>-zeaxanthin.</p></fn><fn id="tab3fn1"><label>*</label><p>MZ levels increased significantly (<italic>P</italic>&#x0003c;0&#x000b7;001) in this study
from baseline to final visit in the enriched egg group (MZ was not measured in the
other studies). All increases or decreases are calculated from the baseline levels
unless otherwise stated.</p></fn></table-wrap-foot></table-wrap>
</p><p>As MZ is not present in non-enriched eggs, and no other studies investigating the
consumption of MZ-enriched eggs have been published, it is difficult to discuss the
between-intervention-group response to MZ in our study. However, the serum MZ response from
the enriched eggs (0&#x000b7;118 &#x000b5;mol/l per mg) in the current study is comparable with that
achieved in oil-based supplementation using commercially available formulations (0&#x000b7;004 and
0&#x000b7;005 &#x000b5;mol/l per mg, respectively)<sup>(</sup>
<xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>,</sup>
<xref rid="ref82" ref-type="bibr">
<sup>82</sup>
</xref>
<sup>)</sup>, but with a considerably lower dosage (0&#x000b7;718 mg, as opposed to 10 and 10 mg,
respectively), and is also greater than the response (0&#x000b7;026 &#x000b5;mol/l per mg) reported by
Thurnham <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref83" ref-type="bibr">
<sup>83</sup>
</xref>
<sup>)</sup>, achieved using an 8-mg supplement. Interestingly, in our study, in the
enriched egg group, observed rises in serum concentrations of CisZ (which is likely to be a
combination of <italic>cis</italic>-Z and <italic>cis</italic>-MZ) were similar to the
observed rises in serum MZ (<xref ref-type="fig" rid="fig3">Fig. 3</xref>), despite the
considerably higher concentrations of MZ compared with CisZ in the raw control egg yolks
(<xref ref-type="fig" rid="fig4">Fig. 4</xref>). There may be several reasons for this
observation, including the following: (1) a portion of yolk MZ (and also possibly yolk Z)
may be metabolised to its respective <italic>cis</italic> form during uptake or absorption,
hence contributing to the overall CisZ response &#x02013; indeed, previous reports have noted
augmentation of serum CisZ in response to supplementation with Z<sup>(</sup>
<xref rid="ref84" ref-type="bibr">
<sup>84</sup>
</xref>
<sup>,</sup>
<xref rid="ref85" ref-type="bibr">
<sup>85</sup>
</xref>
<sup>)</sup>; (2) there may have been thermally induced isomerisation of
<italic>trans</italic>-Z and MZ during the cooking of the eggs, as this has been previously
reported in the case of some vegetables, including maize<sup>(</sup>
<xref rid="ref86" ref-type="bibr">
<sup>86</sup>
</xref>
<sup>)</sup>.</p><p>With respect to the relationship between serum concentrations arising from egg consumption
and MP in our study, we found no significant correlations in either study group over the
8-week intervention period. This finding is in agreement with one previous report<sup>(</sup>
<xref rid="ref76" ref-type="bibr">
<sup>76</sup>
</xref>
<sup>)</sup>, but in contrast to that of others<sup>(</sup>
<xref rid="ref62" ref-type="bibr">
<sup>62</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref64" ref-type="bibr">
<sup>64</sup>
</xref>
<sup>)</sup> (<xref ref-type="table" rid="tab3">Table 3</xref>). When discussing the MP
findings in the current study, it is perhaps worthwhile to note the study of Broekmans
<italic>et al.</italic>
<sup>(</sup>
<xref rid="ref87" ref-type="bibr">
<sup>87</sup>
</xref>
<sup>)</sup>. Interestingly, in that study, in which cross-sectional data were analysed, the
authors found that in a group of 376 subjects (which were almost equally split as regards
sex), MP levels were 13 % higher in men than in women. In contrast, serum carotenoid
concentrations and adipose tissue concentrations of L were significantly higher in women
(however, it is known that there is a higher concentration of adipose tissue in the body
composition of women than in men<sup>(</sup>
<xref rid="ref88" ref-type="bibr">
<sup>88</sup>
</xref>
<sup>)</sup>, and therefore this may naturally have influenced greater L absorption by
adipose tissue in women). The observation that men exhibited lower concentrations of L in
serum and in adipose tissue, and yet higher MP, suggests that men would likely be more
responsive to attempts to augment MP through dietary modification, and that adipose tissue
appears to compete for L with MP&#x02019;s constituent carotenoids, as suggested previously<sup>(</sup>
<xref rid="ref89" ref-type="bibr">
<sup>89</sup>
</xref>
<sup>)</sup>. Hence, it may be important to consider adiposity when reporting the
relationship between carotenoid intake and MP. In relation to the current study, the sex
split was 84 % male and 16 % female in the enriched egg group, and 40 % male and 60 % female
in the control egg group. The fact that we did not see a change in MP in the enriched egg
group in the current study is perhaps unusual, given the predominance of males in that
group. In this regard, it may also be important to highlight that concentrations of
carotenoids in serum reflect more recent dietary intake, whereas adipose tissue
concentrations more accurately reflect longer-term dietary intake of carotenoids<sup>(</sup>
<xref rid="ref89" ref-type="bibr">
<sup>89</sup>
</xref>
<sup>)</sup>, and therefore in a shorter study (such as the current one) serum and adipose
tissue effects on MP density may not have been elicited.</p><p>With regard to visual performance, in our study, the small number of statistically
significant results for letter CS (i.e. one&#x02019;s ability to discriminate the foreground from
the background) and VA (i.e. sharpness of vision at 100 % contrast), which we noted in the
enriched egg group, should be assessed with caution. First, none of the improvements were
clinically significant and, second, the statistical significance that we report (e.g. for
four CS measures in <xref ref-type="table" rid="tab3">Table 2</xref>) may well be a
consequence of multiple testing.</p><p>An improvement in CS without an increase in MP has been noted in a previous study by our
group<sup>(</sup>
<xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>)</sup>, although this was evident at 6 months post intervention. Overall, the lack of
improvement in visual performance of the EXIT subjects is consistent with the lack of MP
augmentation also observed, as it has been shown that CS improvements are typically
commensurate with observed augmentations in MP<sup>(</sup>
<xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>)</sup>. It is also important to note that, as seen in <xref ref-type="table" rid="tab1">Table 1</xref>, the baseline values for BCVA and CS in both subject groups in
our study were considered high, and therefore our finding (of limited clinically meaningful
improvements in their visual performance) is not unexpected, particularly considering the
relatively short duration of the trial. Indeed, we have previously shown that improvements
in visual performance in healthy subjects without AMD are possible over a longer duration
(12 months)<sup>(</sup>
<xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref>
<sup>)</sup>. In addition, in the current study, we considered whether low and high
carotenoid responders may have behaved differently in terms of their visual parameters.
However, this would have reduced group sizes significantly, and after a cursory examination
we felt that such an analysis would be unjustified.</p><p>We showed that total cholesterol levels increased significantly over the 8-week trial
period in both the control egg (9 % increase) and enriched egg (5 % increase) groups, but
upper limits of the normative reference values (6&#x000b7;5 mmol/l) were not exceeded, and this
finding is consistent with previous studies, where total cholesterol increases of 4 %<sup>(</sup>
<xref rid="ref90" ref-type="bibr">
<sup>90</sup>
</xref>
<sup>)</sup> and 5 %<sup>(</sup>
<xref rid="ref91" ref-type="bibr">
<sup>91</sup>
</xref>
<sup>)</sup> were reported. Moreover, we found no significant increases in LDL, HDL or TAG
levels in either study group, consistent with other egg-based studies<sup>(</sup>
<xref rid="ref54" ref-type="bibr">
<sup>54</sup>
</xref>
<sup>,</sup>
<xref rid="ref62" ref-type="bibr">
<sup>62</sup>
</xref>
<sup>,</sup>
<xref rid="ref80" ref-type="bibr">
<sup>80</sup>
</xref>
<sup>)</sup>.</p><p>The limitations of this study include the relatively short study period and small sample
size, the lack of randomisation of the treatment groups and the high male:female ratio in
the enriched egg group. In a follow-up clinical trial, males and females would be randomly
allocated to the two treatment groups, and food colouring could also be added to both trial
supplements to eliminate the need for different locations for both arms of the trial. Of
note, previous work has shown that females responded better to carotenoid supplementation
than males<sup>(</sup>
<xref rid="ref83" ref-type="bibr">
<sup>83</sup>
</xref>
<sup>)</sup>. In addition, it has been reported that carotenoids in an egg matrix may
possibly have significantly lower bioaccessibility, because of reduced retention and
transfer of the carotenoids to the micelles (micellarisation), when cooked by scrambling
(the method chosen in the current study) in comparison with boiling<sup>(</sup>
<xref rid="ref92" ref-type="bibr">
<sup>92</sup>
</xref>
<sup>)</sup>.</p><p>In conclusion, we have shown that consumption of both normal and L- and MZ-enriched eggs
significantly increased serum concentrations of MP&#x02019;s constituent carotenoids after 8 weeks&#x02019;
supplementation. Although measures of MP and the majority of measures of visual performance
did not improve significantly in either study group, and given the observed significant
increases in serum concentrations of MP&#x02019;s constituent carotenoids, we feel that a study of
greater duration is required before definitive conclusions can be drawn on the potential of
carotenoid-enriched eggs to augment MP and/or impact favourably on vision. The finding that
CisZ appeared to have greater bioaccessibility to serum than <italic>trans</italic> Z and MZ
is potentially interesting, and warrants further investigation. In summary,
carotenoid-enriched eggs could represent a cost-effective and readily bioaccessible source
of the macular carotenoids as an alternative to over-the-counter formulations.</p></sec></body><back><ack id="ack1"><title>Acknowledgements</title><p>The authors acknowledge the hen farmers (Kevin McKenna and Colette McKenna) who supported
the original supplementation of the hen&#x02019;s diets and subsequent egg collection on their farm,
and we also thank Industrial Org&#x000e1;nica (S.A. de C.V Ave. Almazan No. 100, Col. Topo Chico,
Monterrey, N.L. 64260, Mexico) for providing the carotenoid material for the trial. The
authors also thank Professor Elizabeth Johnson from Tufts University, USA, for use of the
&#x02018;L/Z screener&#x02019; for the estimation of dietary intake of lutein and zeaxanthin in this study.</p><p>The EXIT clinical trial was supported by the Howard Foundation (English Charity reg. no.
285822), Cambridge, UK. D. K., K. O. A. and J. M. N. are funded by the European Research
Council Starter grant (ref. 281096).</p><p>D. K. carried out database analysis and interpretation, statistical analysis and drafted
the manuscript. J. M. N. and A. N. H. designed and supervised the study. J. S. provided
statistical expertise in both the design of the study and in data analysis. K. O. A. and R.
M. supported visual function and MP analysis and interpretation, and HPLC analysis and
interpretation, respectively. D. I. T. helped to draft the final manuscript. J. D. conducted
subject clinical assessments. K. A. M. carried out the analytical experimental procedures.
S. B. helped to draft the final manuscript.</p><p>All authors have read and approved the manuscript. J. M. N. and S. B. do consultancy work
for nutraceutical companies in a personal capacity and as directors of Nutrasight
Consultancy limited. D. I. T. is a consultant to the Howard Foundation and receives
consulting fees for this service. All other authors report no potential conflicts of
interest.</p></ack><sec sec-type="supplementary-material" id="sec4"><title>Supplementary material</title><supplementary-material content-type="local-data" id="S0007114516003895sup001"><p>For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0007114516003895.</p><media xlink:href="S0007114516003895sup001.doc" mimetype="application" mime-subtype="msword" orientation="portrait" id="d35e5543" position="anchor"><caption><p>click here to view supplementary material</p></caption></media></supplementary-material></sec><ref-list id="refs"><title>References</title><ref id="ref1"><label>1.</label><mixed-citation publication-type="journal">
<name><surname>Meagher</surname><given-names>KA</given-names></name>, <name><surname>Thurnham</surname><given-names>DI</given-names></name>, <name><surname>Beatty</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Serum response to
supplemental macular carotenoids in subjects with and without age-related macular
degeneration</article-title>. <source>Br J Nutr</source>
<volume>110</volume>, <fpage>289</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="pmid">23211762</pub-id></mixed-citation></ref><ref id="ref2"><label>2.</label><mixed-citation publication-type="journal">
<name><surname>Hirsch</surname><given-names>J</given-names></name> &#x00026; <name><surname>Curcio</surname><given-names>CA</given-names></name> (<year>1989</year>) <article-title>The spatial resolution capacity of human foveal
retina</article-title>. <source>Vision Res</source>
<volume>29</volume>, <fpage>1095</fpage>&#x02013;<lpage>1101</lpage>.<pub-id pub-id-type="pmid">2617858</pub-id></mixed-citation></ref><ref id="ref3"><label>3.</label><mixed-citation publication-type="journal">
<name><surname>Bressler</surname><given-names>NM</given-names></name> (<year>2004</year>) <article-title>Age-related macular degeneration is the leading
cause of blindness</article-title>. <source>JAMA</source>
<volume>291</volume>, <fpage>1900</fpage>&#x02013;<lpage>1901</lpage>.<pub-id pub-id-type="pmid">15108691</pub-id></mixed-citation></ref><ref id="ref4"><label>4.</label><mixed-citation publication-type="journal">
<name><surname>Sabour-Pickett</surname><given-names>S</given-names></name>, <name><surname>Nolan</surname><given-names>JM</given-names></name>, <name><surname>Loughman</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>A review of the evidence
germane to the putative protective role of the macular carotenoids for age-related
macular degeneration</article-title>. <source>Mol Nutr Food Res</source>
<volume>10</volume>, <fpage>270</fpage>&#x02013;<lpage>286</lpage>.</mixed-citation></ref><ref id="ref5"><label>5.</label><mixed-citation publication-type="journal">
<name><surname>Loane</surname><given-names>E</given-names></name>, <name><surname>Kelliher</surname><given-names>C</given-names></name>, <name><surname>Beatty</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>The rationale and evidence
base for a protective role of macular pigment in age-related
maculopathy</article-title>. <source>Br J Ophthalmol</source>
<volume>92</volume>, <fpage>1163</fpage>&#x02013;<lpage>1168</lpage>.<pub-id pub-id-type="pmid">18669545</pub-id></mixed-citation></ref><ref id="ref6"><label>6.</label><mixed-citation publication-type="journal">
<name><surname>Pintea</surname><given-names>A</given-names></name>, <name><surname>Socaciu</surname><given-names>C</given-names></name>, <name><surname>Rugina</surname><given-names>DO</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Xanthophylls protect
against induced oxidation in cultured human retinal pigment epithelial
cells</article-title>. <source>J Food Composition Anal</source>
<volume>26</volume>, <fpage>830</fpage>&#x02013;<lpage>836</lpage>.</mixed-citation></ref><ref id="ref7"><label>7.</label><mixed-citation publication-type="journal">
<name><surname>Beatty</surname><given-names>S</given-names></name>, <name><surname>Koh</surname><given-names>HH</given-names></name>, <name><surname>Henson</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>The role of oxidative
stress in the pathogenesis of age-related macular degeneration</article-title>.
<source>Surv Ophthalmol</source>
<volume>45</volume>, <fpage>115</fpage>&#x02013;<lpage>134</lpage>.<pub-id pub-id-type="pmid">11033038</pub-id></mixed-citation></ref><ref id="ref8"><label>8.</label><mixed-citation publication-type="journal">
<name><surname>Trevithick-Sutton</surname><given-names>CC</given-names></name>, <name><surname>Foote</surname><given-names>CS</given-names></name>, <name><surname>Collins</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>The retinal carotenoids
zeaxanthin and lutein scavenge superoxide and hydroxyl radicals: a chemiluminescence and
ESR study</article-title>. <source>Mol Vis</source>
<volume>12</volume>, <fpage>1127</fpage>&#x02013;<lpage>1135</lpage>.<pub-id pub-id-type="pmid">17093397</pub-id></mixed-citation></ref><ref id="ref9"><label>9.</label><mixed-citation publication-type="journal">
<name><surname>Khachik</surname><given-names>F</given-names></name>, <name><surname>Beecher</surname><given-names>GR</given-names></name> &#x00026; <name><surname>Goli</surname><given-names>MB</given-names></name> (<year>1992</year>) <article-title>Separation and identification of carotenoids of
carotenoids and their oxidation products in the extracts of human
plasma</article-title>. <source>Anal Chem</source>
<volume>64</volume>, <fpage>2111</fpage>&#x02013;<lpage>2122</lpage>.<pub-id pub-id-type="pmid">1416048</pub-id></mixed-citation></ref><ref id="ref10"><label>10.</label><mixed-citation publication-type="journal">
<name><surname>Junghans</surname><given-names>A</given-names></name>, <name><surname>Sies</surname><given-names>H</given-names></name> &#x00026; <name><surname>Stahl</surname><given-names>W</given-names></name> (<year>2001</year>) <article-title>Macular pigments lutein and zeaxanthin as blue
light filters studied in liposomes</article-title>. <source>Arch Biochem Biophys</source>
<volume>391</volume>, <fpage>160</fpage>&#x02013;<lpage>164</lpage>.<pub-id pub-id-type="pmid">11437346</pub-id></mixed-citation></ref><ref id="ref11"><label>11.</label><mixed-citation publication-type="journal">
<name><surname>Snodderly</surname><given-names>DM</given-names></name>, <name><surname>Brown</surname><given-names>PK</given-names></name>, <name><surname>Delori</surname><given-names>FC</given-names></name>, <etal>et al</etal> (<year>1984</year>) <article-title>The macular pigment. 1.
Absorbance spectra, localization, and discrimination from other yellow pigments in
primate retinas</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<volume>25</volume>, <fpage>660</fpage>&#x02013;<lpage>673</lpage>.<pub-id pub-id-type="pmid">6724836</pub-id></mixed-citation></ref><ref id="ref12"><label>12.</label><mixed-citation publication-type="journal">
<name><surname>Nolan</surname><given-names>JM</given-names></name>, <name><surname>Loughman</surname><given-names>J</given-names></name>, <name><surname>Akkali</surname><given-names>MC</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>The impact of macular
pigment augmentation on visual performance in normal subjects: COMPASS</article-title>.
<source>Vision Res</source>
<volume>51</volume>, <fpage>459</fpage>&#x02013;<lpage>469</lpage>.<pub-id pub-id-type="pmid">21237188</pub-id></mixed-citation></ref><ref id="ref13"><label>13.</label><mixed-citation publication-type="journal">
<name><surname>Huang</surname><given-names>YM</given-names></name>, <name><surname>Yan</surname><given-names>SF</given-names></name>, <name><surname>Ma</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Serum and macular
responses to multiple xanthophyll supplements in patients with early age-related macular
degeneration</article-title>. <source>Nutrition</source>
<volume>29</volume>, <fpage>387</fpage>&#x02013;<lpage>392</lpage>.<pub-id pub-id-type="pmid">23312760</pub-id></mixed-citation></ref><ref id="ref14"><label>14.</label><mixed-citation publication-type="journal">
<name><surname>Sabour-Pickett</surname><given-names>S</given-names></name>, <name><surname>Beatty</surname><given-names>S</given-names></name>, <name><surname>Connolly</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Supplementation with three
different macular carotenoid formulations in patients with early age-related macular
degeneration</article-title>. <source>Retina</source>
<volume>34</volume>, <fpage>1757</fpage>&#x02013;<lpage>1766</lpage>.<pub-id pub-id-type="pmid">24887490</pub-id></mixed-citation></ref><ref id="ref15"><label>15.</label><mixed-citation publication-type="journal">
<name><surname>Murray</surname><given-names>IJ</given-names></name>, <name><surname>Makridaki</surname><given-names>M</given-names></name>, <name><surname>van der Veen</surname><given-names>RL</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Lutein supplementation
over a one-year period in early AMD might have a mild beneficial effect on visual
acuity: the CLEAR study</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<volume>54</volume>, <fpage>1781</fpage>&#x02013;<lpage>1788</lpage>.<pub-id pub-id-type="pmid">23385792</pub-id></mixed-citation></ref><ref id="ref16"><label>16.</label><mixed-citation publication-type="journal">
<name><surname>Ma</surname><given-names>L</given-names></name>, <name><surname>Yan</surname><given-names>SF</given-names></name>, <name><surname>Huang</surname><given-names>YM</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Effect of lutein and
zeaxanthin on macular pigment and visual function in patients with early age-related
macular degeneration</article-title>. <source>Ophthalmology</source>
<volume>119</volume>, <fpage>2290</fpage>&#x02013;<lpage>2297</lpage>.<pub-id pub-id-type="pmid">22858124</pub-id></mixed-citation></ref><ref id="ref17"><label>17.</label><mixed-citation publication-type="journal">
<name><surname>Peng</surname><given-names>ML</given-names></name>, <name><surname>Chiu</surname><given-names>HF</given-names></name>, <name><surname>Chou</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Influence/impact of lutein
complex (marigold flower and wolfberry) on visual function with early age-related
macular degeneration subjects: a randomized clinical trial</article-title>. <source>J
Funct Foods</source>
<volume>24</volume>, <fpage>122</fpage>&#x02013;<lpage>130</lpage>.</mixed-citation></ref><ref id="ref18"><label>18.</label><mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>T</given-names></name>, <name><surname>Zhang</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Lutein and zeaxanthin
supplementation and association with visual function in age-related macular
degeneration</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<volume>56</volume>, <fpage>252</fpage>&#x02013;<lpage>258</lpage>.</mixed-citation></ref><ref id="ref19"><label>19.</label><mixed-citation publication-type="journal">
<name><surname>Wolf-Schnurrbusch</surname><given-names>UE</given-names></name>, <name><surname>Zinkernagel</surname><given-names>MS</given-names></name>, <name><surname>Munk</surname><given-names>MR</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Oral lutein
supplementation enhances macular pigment density and contrast sensitivity but not in
combination with polyunsaturated fatty acids</article-title>. <source>Invest Ophthalmol
Vis Sci</source>
<volume>56</volume>, <fpage>8069</fpage>&#x02013;<lpage>8074</lpage>.<pub-id pub-id-type="pmid">26720458</pub-id></mixed-citation></ref><ref id="ref20"><label>20.</label><mixed-citation publication-type="journal">
<name><surname>Loughman</surname><given-names>J</given-names></name>, <name><surname>Nolan</surname><given-names>JM</given-names></name>, <name><surname>Howard</surname><given-names>AN</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>The impact of macular
pigment augmentation on visual performance using different carotenoid
formulations</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<volume>53</volume>, <fpage>7871</fpage>&#x02013;<lpage>7880</lpage>.<pub-id pub-id-type="pmid">23132800</pub-id></mixed-citation></ref><ref id="ref21"><label>21.</label><mixed-citation publication-type="journal">
<name><surname>Nolan</surname><given-names>JM</given-names></name>, <name><surname>Power</surname><given-names>R</given-names></name>, <name><surname>Stringham</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Enrichment of macular
pigment enhances contrast sensitivity in subjects free of retinal disease: Central
Retinal Enrichment Supplementation Trials &#x02013; Report 1</article-title>. <source>Invest
Ophthalmol Vis Sci</source>
<volume>57</volume>, <fpage>3429</fpage>&#x02013;<lpage>3439</lpage>.<pub-id pub-id-type="pmid">27367585</pub-id></mixed-citation></ref><ref id="ref22"><label>22.</label><mixed-citation publication-type="journal">
<name><surname>Ozawa</surname><given-names>Y</given-names></name>, <name><surname>Sasaki</surname><given-names>M</given-names></name>, <name><surname>Takahashi</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Neuroprotective effects of
lutein in the retina</article-title>. <source>Curr Pharm Des</source>
<volume>18</volume>, <fpage>51</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">22211688</pub-id></mixed-citation></ref><ref id="ref23"><label>23.</label><mixed-citation publication-type="journal">
<name><surname>Kamoshita</surname><given-names>M</given-names></name>, <name><surname>Toda</surname><given-names>E</given-names></name>, <name><surname>Osada</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Lutein acts via multiple
antioxidant pathways in the photo-stressed retina</article-title>. <source>Sci Rep</source>
<volume>6</volume>, <fpage>30226</fpage>.<pub-id pub-id-type="pmid">27444056</pub-id></mixed-citation></ref><ref id="ref24"><label>24.</label><mixed-citation publication-type="journal">
<name><surname>Vishwanathan</surname><given-names>R</given-names></name>, <name><surname>Neuringer</surname><given-names>M</given-names></name>, <name><surname>Snodderly</surname><given-names>DM</given-names></name>, <etal>et al</etal> (<year>2012</year>) Macular lutein and zeaxanthin are related
to brain lutein and zeaxanthin in primates. <italic>Nutr Neurosci</italic>
<volume>16</volume>, <fpage>21</fpage>&#x02013;<lpage>29</lpage>.</mixed-citation></ref><ref id="ref25"><label>25.</label><mixed-citation publication-type="journal">
<name><surname>Craft</surname><given-names>NE</given-names></name>, <name><surname>Haitema</surname><given-names>TB</given-names></name>, <name><surname>Garnett</surname><given-names>KM</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Carotenoid, tocopherol,
and retinol concentrations in elderly human brain</article-title>. <source>J Nutr Health
Aging</source>
<volume>8</volume>, <fpage>156</fpage>&#x02013;<lpage>162</lpage>.<pub-id pub-id-type="pmid">15129301</pub-id></mixed-citation></ref><ref id="ref26"><label>26.</label><mixed-citation publication-type="journal">
<name><surname>Vishwanathan</surname><given-names>R</given-names></name>, <name><surname>Kuchan</surname><given-names>MJ</given-names></name>, <name><surname>Sen</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Lutein and preterm infants
with decreased concentrations of brain carotenoids</article-title>. <source>J Pediatr
Gastroenterol Nutr</source>
<volume>59</volume>, <fpage>659</fpage>&#x02013;<lpage>665</lpage>.<pub-id pub-id-type="pmid">24691400</pub-id></mixed-citation></ref><ref id="ref27"><label>27.</label><mixed-citation publication-type="journal">
<name><surname>Johnson</surname><given-names>EJ</given-names></name>, <name><surname>Vishwanathan</surname><given-names>R</given-names></name>, <name><surname>Johnson</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Relationship between serum
and brain carotenoids, alpha-tocopherol, and retinol concentrations and cognitive
performance in the oldest old from the Georgia Centenarian Study</article-title>.
<source>J Aging Res</source>
<volume>2013</volume>, <fpage>951786</fpage>.<pub-id pub-id-type="pmid">23840953</pub-id></mixed-citation></ref><ref id="ref28"><label>28.</label><mixed-citation publication-type="journal">
<name><surname>Kelly</surname><given-names>D</given-names></name>, <name><surname>Coen</surname><given-names>RF</given-names></name>, <name><surname>Akuffo</surname><given-names>KO</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Cognitive function and its
relationship with macular pigment optical density and serum concentrations of its
constituent carotenoids</article-title>. <source>J Alzheimers Dis</source>
<volume>48</volume>, <fpage>261</fpage>&#x02013;<lpage>277</lpage>.<pub-id pub-id-type="pmid">26401946</pub-id></mixed-citation></ref><ref id="ref29"><label>29.</label><mixed-citation publication-type="journal">
<name><surname>Vishwanathan</surname><given-names>R</given-names></name>, <name><surname>Iannaccone</surname><given-names>A</given-names></name>, <name><surname>Scott</surname><given-names>TM</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Macular pigment optical
density is related to cognitive function in older people</article-title>. <source>Age
Ageing</source>
<volume>43</volume>, <fpage>271</fpage>&#x02013;<lpage>275</lpage>.<pub-id pub-id-type="pmid">24435852</pub-id></mixed-citation></ref><ref id="ref30"><label>30.</label><mixed-citation publication-type="journal">
<name><surname>Renzi</surname><given-names>LM</given-names></name>, <name><surname>Dengler</surname><given-names>MJ</given-names></name>, <name><surname>Puente</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Relationships between
macular pigment optical density and cognitive function in unimpaired and mildly
cognitively impaired older adults</article-title>. <source>Neurobiol Aging</source>
<volume>35</volume>, <fpage>1695</fpage>&#x02013;<lpage>1699</lpage>.<pub-id pub-id-type="pmid">24508218</pub-id></mixed-citation></ref><ref id="ref31"><label>31.</label><mixed-citation publication-type="journal">
<name><surname>Johnson</surname><given-names>EJ</given-names></name>, <name><surname>Vishwanathan</surname><given-names>R</given-names></name> &#x00026; <name><surname>Schalch</surname><given-names>W</given-names></name> (<year>2011</year>) <article-title>Brain levels of lutein (L) and zeaxanthin (Z)
are related to cognitive function in centenarians</article-title>. <source>FASEB J</source>
<volume>25</volume>, <fpage>1 Suppl., 975.21</fpage>.<pub-id pub-id-type="pmid">21205780</pub-id></mixed-citation></ref><ref id="ref32"><label>32.</label><mixed-citation publication-type="journal">
<name><surname>Imran</surname><given-names>M</given-names></name>, <name><surname>Anjum</surname><given-names>FM</given-names></name>, <name><surname>Nadeem</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Production of bio-omega-3
eggs through the supplementation of extruded flaxseed meal in hen diet</article-title>.
<source>Lipids Health Dis</source>
<volume>14</volume>, <fpage>126</fpage>.<pub-id pub-id-type="pmid">26453429</pub-id></mixed-citation></ref><ref id="ref33"><label>33.</label><mixed-citation publication-type="journal">
<name><surname>Goldberg</surname><given-names>EM</given-names></name>, <name><surname>Gakhar</surname><given-names>N</given-names></name>, <name><surname>Ryland</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Fatty acid profile and
sensory characteristics of table eggs from laying hens fed hempseed and hempseed
oil</article-title>. <source>J Food Sci</source>
<volume>77</volume>, <fpage>S153</fpage>&#x02013;<lpage>S160</lpage>.<pub-id pub-id-type="pmid">22429187</pub-id></mixed-citation></ref><ref id="ref34"><label>34.</label><mixed-citation publication-type="journal">
<name><surname>Lewis</surname><given-names>NM</given-names></name>, <name><surname>Seburg</surname><given-names>S</given-names></name> &#x00026; <name><surname>Flanagan</surname><given-names>NL</given-names></name> (<year>2000</year>) <article-title>Enriched eggs as a source of
<italic>n</italic>-3 polyunsaturated fatty acids for humans</article-title>.
<source>Poult Sci</source>
<volume>79</volume>, <fpage>971</fpage>&#x02013;<lpage>974</lpage>.<pub-id pub-id-type="pmid">10901195</pub-id></mixed-citation></ref><ref id="ref35"><label>35.</label><mixed-citation publication-type="journal">
<name><surname>Goldberg</surname><given-names>EM</given-names></name>, <name><surname>Ryland</surname><given-names>D</given-names></name>, <name><surname>Gibson</surname><given-names>RA</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Designer laying hen diets
to improve egg fatty acid profile and maintain sensory quality</article-title>.
<source>Food Sci Nutr</source>
<volume>1</volume>, <fpage>324</fpage>&#x02013;<lpage>335</lpage>.<pub-id pub-id-type="pmid">24804037</pub-id></mixed-citation></ref><ref id="ref36"><label>36.</label><mixed-citation publication-type="journal">
<name><surname>Stergiadis</surname><given-names>S</given-names></name>, <name><surname>Leifert</surname><given-names>C</given-names></name>, <name><surname>Seal</surname><given-names>CJ</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Improving the fatty acid
profile of winter milk from housed cows with contrasting feeding regimes by oilseed
supplementation</article-title>. <source>Food Chem</source>
<volume>164</volume>, <fpage>293</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="pmid">24996337</pub-id></mixed-citation></ref><ref id="ref37"><label>37.</label><mixed-citation publication-type="journal">
<name><surname>Rahmawaty</surname><given-names>S</given-names></name>, <name><surname>Lyons-Wall</surname><given-names>P</given-names></name>, <name><surname>Charlton</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Effect of replacing bread,
egg, milk, and yogurt with equivalent omega-3 enriched foods on omega-3 LCPUFA intake of
Australian children</article-title>. <source>Nutrition</source>
<volume>30</volume>, <fpage>1337</fpage>&#x02013;<lpage>1343</lpage>.<pub-id pub-id-type="pmid">25280409</pub-id></mixed-citation></ref><ref id="ref38"><label>38.</label><mixed-citation publication-type="journal">
<name><surname>Thurnham</surname><given-names>DI</given-names></name> (<year>2007</year>) <article-title>Macular zeaxanthins and lutein &#x02013; a review of
dietary sources and bioavailability and some relationships with macular pigment optical
density and age-related macular disease</article-title>. <source>Nutr Res Rev</source>
<volume>20</volume>, <fpage>163</fpage>&#x02013;<lpage>179</lpage>.<pub-id pub-id-type="pmid">19079868</pub-id></mixed-citation></ref><ref id="ref39"><label>39.</label><mixed-citation publication-type="journal">
<name><surname>Sommerburg</surname><given-names>O</given-names></name>, <name><surname>Keunen</surname><given-names>JE</given-names></name>, <name><surname>Bird</surname><given-names>AC</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Fruits and vegetables that
are sources for lutein and zeaxanthin: the macular pigment in human
eyes</article-title>. <source>Br J Ophthalmol</source>
<volume>82</volume>, <fpage>907</fpage>&#x02013;<lpage>910</lpage>.<pub-id pub-id-type="pmid">9828775</pub-id></mixed-citation></ref><ref id="ref40"><label>40.</label><mixed-citation publication-type="journal">
<name><surname>Perry</surname><given-names>A</given-names></name>, <name><surname>Rasmussen</surname><given-names>H</given-names></name> &#x00026; <name><surname>Johnson</surname><given-names>EJ</given-names></name> (<year>2009</year>) <article-title>Xanthophyll (lutein, zeaxanthin) content in
fruits, vegetables and corn and egg products</article-title>. <source>J Food Composition
Anal</source>
<volume>22</volume>, <fpage>9</fpage>&#x02013;<lpage>15</lpage>.</mixed-citation></ref><ref id="ref41"><label>41.</label><mixed-citation publication-type="journal">
<name><surname>Maoka</surname><given-names>T</given-names></name>, <name><surname>Arai</surname><given-names>A</given-names></name>, <name><surname>Shimizu</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>1986</year>) <article-title>The first isolation of
enantiomeric and meso-zeaxanthin in nature</article-title>. <source>Comp Biochem Physiol
B</source>
<volume>83</volume>, <fpage>121</fpage>&#x02013;<lpage>124</lpage>.<pub-id pub-id-type="pmid">3943294</pub-id></mixed-citation></ref><ref id="ref42"><label>42.</label><mixed-citation publication-type="journal">
<name><surname>Nolan</surname><given-names>JM</given-names></name>, <name><surname>Beatty</surname><given-names>S</given-names></name>, <name><surname>Meagher</surname><given-names>KA</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Verification of zeaxanthin
in Fish</article-title>. <source>J Food Process Technol</source>
<volume>5</volume>, <fpage>335</fpage>.<pub-id pub-id-type="pmid">25717420</pub-id></mixed-citation></ref><ref id="ref43"><label>43.</label><mixed-citation publication-type="journal">
<name><surname>Bone</surname><given-names>RA</given-names></name>, <name><surname>Landrum</surname><given-names>JT</given-names></name>, <name><surname>Hime</surname><given-names>GW</given-names></name>, <etal>et al</etal> (<year>1993</year>) <article-title>Stereochemistry of the
human macular carotenoids</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<volume>34</volume>, <fpage>2033</fpage>&#x02013;<lpage>2040</lpage>.<pub-id pub-id-type="pmid">8491553</pub-id></mixed-citation></ref><ref id="ref44"><label>44.</label><mixed-citation publication-type="journal">
<name><surname>Johnson</surname><given-names>EJ</given-names></name>, <name><surname>Neuringer</surname><given-names>M</given-names></name>, <name><surname>Russell</surname><given-names>RM</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Nutritional manipulation
of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose
tissue and retina of xanthophyll-free monkeys</article-title>. <source>Invest Ophthalmol
Vis Sci</source>
<volume>46</volume>, <fpage>692</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="pmid">15671301</pub-id></mixed-citation></ref><ref id="ref45"><label>45.</label><mixed-citation publication-type="journal">
<name><surname>Nolan</surname><given-names>JM</given-names></name>, <name><surname>Meagher</surname><given-names>K</given-names></name>, <name><surname>Kashani</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>What is meso-zeaxanthin,
and where does it come from?</article-title>
<source>Eye (Lond)</source>
<volume>27</volume>, <fpage>899</fpage>&#x02013;<lpage>905</lpage>.<pub-id pub-id-type="pmid">23703634</pub-id></mixed-citation></ref><ref id="ref46"><label>46.</label><mixed-citation publication-type="journal">
<name><surname>Bone</surname><given-names>RA</given-names></name>, <name><surname>Landrum</surname><given-names>JT</given-names></name>, <name><surname>Friedes</surname><given-names>LM</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>Distribution of lutein and
zeaxanthin stereoisomers in the human retina</article-title>. <source>Exp Eye Res</source>
<volume>64</volume>, <fpage>211</fpage>&#x02013;<lpage>218</lpage>.<pub-id pub-id-type="pmid">9176055</pub-id></mixed-citation></ref><ref id="ref47"><label>47.</label><mixed-citation publication-type="journal">
<name><surname>Li</surname><given-names>B</given-names></name>, <name><surname>Ahmed</surname><given-names>F</given-names></name> &#x00026; <name><surname>Bernstein</surname><given-names>PS</given-names></name> (<year>2010</year>) Studies on the singlet oxygen scavenging mechanism of human
macular pigment. <italic>Arch Biochem Biophys</italic>
<volume>504</volume>, <fpage>56</fpage>&#x02013;<lpage>60</lpage>.</mixed-citation></ref><ref id="ref48"><label>48.</label><mixed-citation publication-type="journal">
<name><surname>Handelman</surname><given-names>GJ</given-names></name>, <name><surname>Nightingale</surname><given-names>ZD</given-names></name>, <name><surname>Lichtenstein</surname><given-names>AH</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>Lutein and zeaxanthin
concentrations in plasma after dietary supplementation with egg yolk</article-title>.
<source>Am J Clin Nutr</source>
<volume>70</volume>, <fpage>247</fpage>&#x02013;<lpage>251</lpage>.<pub-id pub-id-type="pmid">10426702</pub-id></mixed-citation></ref><ref id="ref49"><label>49.</label><mixed-citation publication-type="journal">
<name><surname>Rich</surname><given-names>GT</given-names></name>, <name><surname>Bailey</surname><given-names>AL</given-names></name>, <name><surname>Faulks</surname><given-names>RM</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Solubilization of
carotenoids from carrot juice and spinach in lipid phases: I. Modeling the gastric
lumen</article-title>. <source>Lipids</source>
<volume>38</volume>, <fpage>933</fpage>&#x02013;<lpage>945</lpage>.<pub-id pub-id-type="pmid">14584601</pub-id></mixed-citation></ref><ref id="ref50"><label>50.</label><mixed-citation publication-type="journal">
<name><surname>Erdman</surname><given-names>JW</given-names><suffix>Jr</suffix></name>, <name><surname>Bierer</surname><given-names>TL</given-names></name> &#x00026; <name><surname>Gugger</surname><given-names>ET</given-names></name> (<year>1993</year>) <article-title>Absorption and transport of
carotenoids</article-title>. <source>Ann N Y Acad Sci</source>
<volume>691</volume>, <fpage>76</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">8129321</pub-id></mixed-citation></ref><ref id="ref51"><label>51.</label><mixed-citation publication-type="journal">
<name><surname>Rock</surname><given-names>CL</given-names></name>, <name><surname>Lovalvo</surname><given-names>JL</given-names></name>, <name><surname>Emenhiser</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Bioavailability of
beta-carotene is lower in raw than in processed carrots and spinach in
women</article-title>. <source>J Nutr</source>
<volume>128</volume>, <fpage>913</fpage>&#x02013;<lpage>916</lpage>.<pub-id pub-id-type="pmid">9567003</pub-id></mixed-citation></ref><ref id="ref52"><label>52.</label><mixed-citation publication-type="journal">
<name><surname>Yeum</surname><given-names>KJ</given-names></name> &#x00026; <name><surname>Russell</surname><given-names>RM</given-names></name> (<year>2002</year>) <article-title>Carotenoid bioavailability and
bioconversion</article-title>. <source>Annu Rev Nutr</source>
<volume>22</volume>, <fpage>483</fpage>&#x02013;<lpage>504</lpage>.<pub-id pub-id-type="pmid">12055355</pub-id></mixed-citation></ref><ref id="ref53"><label>53.</label><mixed-citation publication-type="journal">
<name><surname>Courraud</surname><given-names>J</given-names></name>, <name><surname>Berger</surname><given-names>J</given-names></name>, <name><surname>Cristol</surname><given-names>JP</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Stability and
bioaccessibility of different forms of carotenoids and vitamin A during <italic>in
vitro</italic> digestion</article-title>. <source>Food Chem</source>
<volume>136</volume>, <fpage>871</fpage>&#x02013;<lpage>877</lpage>.<pub-id pub-id-type="pmid">23122139</pub-id></mixed-citation></ref><ref id="ref54"><label>54.</label><mixed-citation publication-type="journal">
<name><surname>Goodrow</surname><given-names>EF</given-names></name>, <name><surname>Wilson</surname><given-names>TA</given-names></name>, <name><surname>Houde</surname><given-names>SC</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Consumption of one egg per
day increases serum lutein and zeaxanthin concentrations in older adults without
altering serum lipid and lipoprotein cholesterol concentrations</article-title>.
<source>J Nutr</source>
<volume>136</volume>, <fpage>2519</fpage>&#x02013;<lpage>2524</lpage>.<pub-id pub-id-type="pmid">16988120</pub-id></mixed-citation></ref><ref id="ref55"><label>55.</label><mixed-citation publication-type="journal">
<name><surname>Chung</surname><given-names>HY</given-names></name>, <name><surname>Rasmussen</surname><given-names>HM</given-names></name> &#x00026; <name><surname>Johnson</surname><given-names>EJ</given-names></name> (<year>2004</year>) <article-title>Lutein bioavailability is higher from
lutein-enriched eggs than from supplements and spinach in men</article-title>. <source>J
Nutr</source>
<volume>134</volume>, <fpage>1887</fpage>&#x02013;<lpage>1893</lpage>.<pub-id pub-id-type="pmid">15284371</pub-id></mixed-citation></ref><ref id="ref56"><label>56.</label><mixed-citation publication-type="journal">
<name><surname>Hammond</surname><given-names>BR</given-names></name>, <name><surname>Johnson</surname><given-names>EJ</given-names></name>, <name><surname>Russell</surname><given-names>RM</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>Dietary modification of
human macular pigment density</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<volume>38</volume>, <fpage>1795</fpage>&#x02013;<lpage>1801</lpage>.<pub-id pub-id-type="pmid">9286268</pub-id></mixed-citation></ref><ref id="ref57"><label>57.</label><mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>W</given-names></name>, <name><surname>Connor</surname><given-names>SL</given-names></name>, <name><surname>Johnson</surname><given-names>EJ</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Effect of dietary lutein
and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related
macular degeneration</article-title>. <source>Am J Clin Nutr</source>
<volume>85</volume>, <fpage>762</fpage>&#x02013;<lpage>769</lpage>.<pub-id pub-id-type="pmid">17344498</pub-id></mixed-citation></ref><ref id="ref58"><label>58.</label><mixed-citation publication-type="journal">
<name><surname>Loane</surname><given-names>E</given-names></name>, <name><surname>Nolan</surname><given-names>JM</given-names></name> &#x00026; <name><surname>Beatty</surname><given-names>S</given-names></name> (<year>2010</year>) <article-title>The respective relationships between
lipoprotein profile, macular pigment optical density, and serum concentrations of lutein
and zeaxanthin</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<volume>51</volume>, <fpage>5897</fpage>&#x02013;<lpage>5905</lpage>.<pub-id pub-id-type="pmid">20574027</pub-id></mixed-citation></ref><ref id="ref59"><label>59.</label><mixed-citation publication-type="journal">
<name><surname>Greene</surname><given-names>CM</given-names></name>, <name><surname>Waters</surname><given-names>D</given-names></name>, <name><surname>Clark</surname><given-names>RM</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Plasma LDL and HDL
characteristics and carotenoid content are positively influenced by egg consumption in
an elderly population</article-title>. <source>Nutr Metab (Lond)</source>
<volume>3</volume>, <fpage>6</fpage>.<pub-id pub-id-type="pmid">16398934</pub-id></mixed-citation></ref><ref id="ref60"><label>60.</label><mixed-citation publication-type="journal">
<name><surname>McNamara</surname><given-names>DJ</given-names></name> (<year>2015</year>) <article-title>The Fifty Year Rehabilitation of the
Egg</article-title>. <source>Nutrients</source>
<volume>7</volume>, <fpage>8716</fpage>&#x02013;<lpage>8722</lpage>.<pub-id pub-id-type="pmid">26506379</pub-id></mixed-citation></ref><ref id="ref61"><label>61.</label><mixed-citation publication-type="journal">
<name><surname>Thurnham</surname><given-names>DI</given-names></name>, <name><surname>Nolan</surname><given-names>JM</given-names></name>, <name><surname>Howard</surname><given-names>AN</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Macular response to
supplementation with differing xanthophyll formulations in subjects with and without
age-related macular degeneration</article-title>. <source>Graefes Arch Clin Exp
Ophthalmol</source>
<volume>253</volume>, <fpage>1231</fpage>&#x02013;<lpage>1243</lpage>.<pub-id pub-id-type="pmid">25311651</pub-id></mixed-citation></ref><ref id="ref62"><label>62.</label><mixed-citation publication-type="journal">
<name><surname>Wenzel</surname><given-names>AJ</given-names></name>, <name><surname>Gerweck</surname><given-names>C</given-names></name>, <name><surname>Barbato</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>A 12-wk egg intervention
increases serum zeaxanthin and macular pigment optical density in women</article-title>.
<source>J Nutr</source>
<volume>136</volume>, <fpage>2568</fpage>&#x02013;<lpage>2573</lpage>.<pub-id pub-id-type="pmid">16988128</pub-id></mixed-citation></ref><ref id="ref63"><label>63.</label><mixed-citation publication-type="journal">
<name><surname>Vishwanathan</surname><given-names>R</given-names></name>, <name><surname>Goodrow-Kotyla</surname><given-names>EF</given-names></name>, <name><surname>Wooten</surname><given-names>BR</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Consumption of 2 and 4 egg
yolks/d for 5 wk increases macular pigment concentrations in older adults with low
macular pigment taking cholesterol-lowering statins</article-title>. <source>Am J Clin
Nutr</source>
<volume>90</volume>, <fpage>1272</fpage>&#x02013;<lpage>1279</lpage>.<pub-id pub-id-type="pmid">19759170</pub-id></mixed-citation></ref><ref id="ref64"><label>64.</label><mixed-citation publication-type="journal">
<name><surname>van der Made</surname><given-names>SM</given-names></name>, <name><surname>Kelly</surname><given-names>ER</given-names></name>, <name><surname>Kijlstra</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Increased macular pigment
optical density and visual acuity following consumption of a buttermilk drink containing
lutein-enriched egg yolks: a randomized, double-blind, placebo-controlled
trial</article-title>. <source>J Ophthalmol</source>
<volume>2016</volume>, <fpage>9035745</fpage>.<pub-id pub-id-type="pmid">27064326</pub-id></mixed-citation></ref><ref id="ref65"><label>65.</label><mixed-citation publication-type="journal">
<name><surname>Nolan</surname><given-names>JM</given-names></name>, <name><surname>Meagher</surname><given-names>KA</given-names></name>, <name><surname>Howard</surname><given-names>AN</given-names></name>, <etal>et al</etal> (<year>2016</year>) <article-title>Lutein, zeaxanthin and
meso-zeaxanthin content of eggs laid by hens supplemented with free and esterified
xanthophylls</article-title>. <source>J Nutr Sci</source>
<volume>5</volume>, <fpage>e1</fpage>.<pub-id pub-id-type="pmid">26793307</pub-id></mixed-citation></ref><ref id="ref66"><label>66.</label><mixed-citation publication-type="journal">
<name><surname>Wooten</surname><given-names>BR</given-names></name> &#x00026; <name><surname>Hammond</surname><given-names>BR</given-names></name> (<year>2005</year>) <article-title>Spectral absorbance and spatial distribution of
macular pigment using heterochromatic flicker photometry</article-title>. <source>Optom
Vis Sci</source>
<volume>82</volume>, <fpage>378</fpage>&#x02013;<lpage>386</lpage>.<pub-id pub-id-type="pmid">15894914</pub-id></mixed-citation></ref><ref id="ref67"><label>67.</label><mixed-citation publication-type="journal">
<name><surname>Wooten</surname><given-names>BR</given-names></name>, <name><surname>Hammond</surname><given-names>BR</given-names></name>, <name><surname>Land</surname><given-names>RI</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>A practical method for
measuring macular pigment optical density</article-title>. <source>Invest Ophthalmol Vis
Sci</source>
<volume>40</volume>, <fpage>2481</fpage>&#x02013;<lpage>2489</lpage>.<pub-id pub-id-type="pmid">10509640</pub-id></mixed-citation></ref><ref id="ref68"><label>68.</label><mixed-citation publication-type="journal">
<name><surname>Loane</surname><given-names>E</given-names></name>, <name><surname>Stack</surname><given-names>J</given-names></name>, <name><surname>Beatty</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Measurement of macular
pigment optical density using two different heterochromatic flicker
photometers</article-title>. <source>Curr Eye Res</source>
<volume>32</volume>, <fpage>555</fpage>&#x02013;<lpage>564</lpage>.<pub-id pub-id-type="pmid">17612971</pub-id></mixed-citation></ref><ref id="ref69"><label>69.</label><mixed-citation publication-type="journal">
<name><surname>Stringham</surname><given-names>JM</given-names></name>, <name><surname>Hammond</surname><given-names>BR</given-names></name>, <name><surname>Nolan</surname><given-names>JM</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>The utility of using
customized heterochromatic flicker photometry (cHFP) to measure macular pigment in
patients with age-related macular degeneration</article-title>. <source>Exp Eye Res</source>
<volume>87</volume>, <fpage>445</fpage>&#x02013;<lpage>453</lpage>.<pub-id pub-id-type="pmid">18778703</pub-id></mixed-citation></ref><ref id="ref70"><label>70.</label><mixed-citation publication-type="journal">
<name><surname>Delori</surname><given-names>FC</given-names></name>, <name><surname>Goger</surname><given-names>DG</given-names></name>, <name><surname>Hammond</surname><given-names>BR</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Macular pigment density
measured by autofluorescence spectrometry: comparison with reflectometry and
heterochromatic flicker photometry</article-title>. <source>J Opt Soc Am A Opt Image Sci
Vis</source>
<volume>18</volume>, <fpage>1212</fpage>&#x02013;<lpage>1230</lpage>.<pub-id pub-id-type="pmid">11393613</pub-id></mixed-citation></ref><ref id="ref71"><label>71.</label><mixed-citation publication-type="journal">
<name><surname>Wustemeyer</surname><given-names>H</given-names></name>, <name><surname>Jahn</surname><given-names>C</given-names></name>, <name><surname>Nestler</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>A new instrument for the
quantification of macular pigment density: first results in patients with AMD and
healthy subjects</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source>
<volume>240</volume>, <fpage>666</fpage>&#x02013;<lpage>671</lpage>.<pub-id pub-id-type="pmid">12192461</pub-id></mixed-citation></ref><ref id="ref72"><label>72.</label><mixed-citation publication-type="journal">
<name><surname>Hohberger</surname><given-names>B</given-names></name>, <name><surname>Laemmer</surname><given-names>R</given-names></name>, <name><surname>Adler</surname><given-names>W</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Measuring contrast
sensitivity in normal subjects with OPTEC 6500: influence of age and
glare</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source>
<volume>245</volume>, <fpage>1805</fpage>&#x02013;<lpage>1814</lpage>.<pub-id pub-id-type="pmid">17694315</pub-id></mixed-citation></ref><ref id="ref73"><label>73.</label><mixed-citation publication-type="journal">
<name><surname>Akuffo</surname><given-names>KO</given-names></name>, <name><surname>Beatty</surname><given-names>S</given-names></name>, <name><surname>Stack</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Central Retinal Enrichment
Supplementation Trials (CREST): design and methodology of the CREST randomized
controlled trials</article-title>. <source>Ophthalmic Epidemiol</source>
<volume>21</volume>, <fpage>111</fpage>&#x02013;<lpage>123</lpage>.<pub-id pub-id-type="pmid">24621122</pub-id></mixed-citation></ref><ref id="ref74"><label>74.</label><mixed-citation publication-type="journal">
<name><surname>Nolan</surname><given-names>JM</given-names></name>, <name><surname>Loskutova</surname><given-names>E</given-names></name>, <name><surname>Howard</surname><given-names>AN</given-names></name>, <etal>et al</etal> (<year>2014</year>) Macular pigment, visual function, and
macular disease among subjects with alzheimer&#x02019;s disease: an exploratory study. <italic>J
Alzheimers Dis</italic>
<volume>42</volume>, <fpage>1191</fpage>&#x02013;<lpage>1202</lpage>.</mixed-citation></ref><ref id="ref75"><label>75.</label><mixed-citation publication-type="journal">
<name><surname>Blesso</surname><given-names>CN</given-names></name>, <name><surname>Andersen</surname><given-names>CJ</given-names></name>, <name><surname>Bolling</surname><given-names>BW</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Egg intake improves
carotenoid status by increasing plasma HDL cholesterol in adults with metabolic
syndrome</article-title>. <source>Food Funct</source>
<volume>4</volume>, <fpage>213</fpage>&#x02013;<lpage>221</lpage>.<pub-id pub-id-type="pmid">23128450</pub-id></mixed-citation></ref><ref id="ref76"><label>76.</label><mixed-citation publication-type="journal">
<name><surname>Kelly</surname><given-names>ER</given-names></name>, <name><surname>Plat</surname><given-names>J</given-names></name>, <name><surname>Haenen</surname><given-names>GR</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>The effect of modified
eggs and an egg-yolk based beverage on serum lutein and zeaxanthin concentrations and
macular pigment optical density: results from a randomized trial</article-title>.
<source>PLOS ONE</source>
<volume>9</volume>, <fpage>e92659</fpage>.<pub-id pub-id-type="pmid">24675775</pub-id></mixed-citation></ref><ref id="ref77"><label>77.</label><mixed-citation publication-type="journal">
<name><surname>Mutungi</surname><given-names>G</given-names></name>, <name><surname>Waters</surname><given-names>D</given-names></name>, <name><surname>Ratliff</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Eggs distinctly modulate
plasma carotenoid and lipoprotein subclasses in adult men following a
carbohydrate-restricted diet</article-title>. <source>J Nutr Biochem</source>
<volume>21</volume>, <fpage>261</fpage>&#x02013;<lpage>267</lpage>.<pub-id pub-id-type="pmid">19369056</pub-id></mixed-citation></ref><ref id="ref78"><label>78.</label><mixed-citation publication-type="journal">
<name><surname>van der Made</surname><given-names>SM</given-names></name>, <name><surname>Kelly</surname><given-names>ER</given-names></name>, <name><surname>Berendschot</surname><given-names>TT</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Consuming a buttermilk
drink containing lutein-enriched egg yolk daily for 1 year increased plasma lutein but
did not affect serum lipid or lipoprotein concentrations in adults with early signs of
age-related macular degeneration</article-title>. <source>J Nutr</source>
<volume>144</volume>, <fpage>1370</fpage>&#x02013;<lpage>1377</lpage>.<pub-id pub-id-type="pmid">24991045</pub-id></mixed-citation></ref><ref id="ref79"><label>79.</label><mixed-citation publication-type="journal">
<name><surname>Surai</surname><given-names>PF</given-names></name>, <name><surname>MacPherson</surname><given-names>A</given-names></name>, <name><surname>Speake</surname><given-names>BK</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Designer egg evaluation in
a controlled trial</article-title>. <source>Eur J Clin Nutr</source>
<volume>54</volume>, <fpage>298</fpage>&#x02013;<lpage>305</lpage>.<pub-id pub-id-type="pmid">10745280</pub-id></mixed-citation></ref><ref id="ref80"><label>80.</label><mixed-citation publication-type="journal">
<name><surname>Bunger</surname><given-names>M</given-names></name>, <name><surname>Quataert</surname><given-names>M</given-names></name>, <name><surname>Kamps</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Bioavailability of lutein
from a lutein-enriched egg-yolk beverage and its dried re-suspended
versions</article-title>. <source>Int J Food Sci Nutr</source>
<volume>65</volume>, <fpage>903</fpage>&#x02013;<lpage>909</lpage>.<pub-id pub-id-type="pmid">25017577</pub-id></mixed-citation></ref><ref id="ref81"><label>81.</label><mixed-citation publication-type="journal">
<name><surname>Nimalaratne</surname><given-names>C</given-names></name>, <name><surname>Lopes-Lutz</surname><given-names>D</given-names></name>, <name><surname>Schieber</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Effect of domestic cooking
methods on egg yolk xanthophylls</article-title>. <source>J Agric Food Chem</source>
<volume>60</volume>, <fpage>12547</fpage>&#x02013;<lpage>12552</lpage>.<pub-id pub-id-type="pmid">23205520</pub-id></mixed-citation></ref><ref id="ref82"><label>82.</label><mixed-citation publication-type="journal">
<name><surname>Connolly</surname><given-names>EE</given-names></name>, <name><surname>Beatty</surname><given-names>S</given-names></name>, <name><surname>Thurnham</surname><given-names>DI</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Augmentation of macular
pigment following supplementation with all three macular carotenoids: an exploratory
study</article-title>. <source>Curr Eye Res</source>
<volume>35</volume>, <fpage>335</fpage>&#x02013;<lpage>351</lpage>.<pub-id pub-id-type="pmid">20373901</pub-id></mixed-citation></ref><ref id="ref83"><label>83.</label><mixed-citation publication-type="journal">
<name><surname>Thurnham</surname><given-names>DI</given-names></name>, <name><surname>Tremel</surname><given-names>A</given-names></name> &#x00026; <name><surname>Howard</surname><given-names>AN</given-names></name> (<year>2008</year>) <article-title>A supplementation study in human subjects with
a combination of meso-zeaxanthin, (3R,3&#x02019;R)-zeaxanthin and
(3R,3&#x02019;R,6&#x02019;R)-lutein</article-title>. <source>Br J Nutr</source>
<volume>100</volume>, <fpage>1307</fpage>&#x02013;<lpage>1314</lpage>.<pub-id pub-id-type="pmid">18405400</pub-id></mixed-citation></ref><ref id="ref84"><label>84.</label><mixed-citation publication-type="journal">
<name><surname>Landrum</surname><given-names>JT</given-names></name> &#x00026; <name><surname>Bone</surname><given-names>RA</given-names></name> (<year>2001</year>) <article-title>Lutein, zeaxanthin, and the macular
pigment</article-title>. <source>Arch Biochem Biophys</source>
<volume>385</volume>, <fpage>28</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">11361022</pub-id></mixed-citation></ref><ref id="ref85"><label>85.</label><mixed-citation publication-type="journal">
<name><surname>Khachik</surname><given-names>F</given-names></name>, <name><surname>Bernstein</surname><given-names>PS</given-names></name> &#x00026; <name><surname>Garland</surname><given-names>DL</given-names></name> (<year>1997</year>) <article-title>Identification of lutein and zeaxanthin
oxidation products in human and monkey retinas</article-title>. <source>Invest
Ophthalmol Vis Sci</source>
<volume>38</volume>, <fpage>1802</fpage>&#x02013;<lpage>1811</lpage>.<pub-id pub-id-type="pmid">9286269</pub-id></mixed-citation></ref><ref id="ref86"><label>86.</label><mixed-citation publication-type="journal">
<name><surname>Aman</surname><given-names>R</given-names></name>, <name><surname>Biehl</surname><given-names>J</given-names></name>, <name><surname>Carle</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Application of HPLC
coupled with DAD, APcI-MS and NMR to the analysis of lutein and zeaxanthin stereoisomers
in thermally processed vegetables</article-title>. <source>Food Chem</source>
<volume>92</volume>, <fpage>753</fpage>&#x02013;<lpage>763</lpage>.</mixed-citation></ref><ref id="ref87"><label>87.</label><mixed-citation publication-type="journal">
<name><surname>Broekmans</surname><given-names>WM</given-names></name>, <name><surname>Berendschot</surname><given-names>TT</given-names></name>, <name><surname>Klopping-Ketelaars</surname><given-names>IA</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Macular pigment density in
relation to serum and adipose tissue concentrations of lutein and serum concentrations
of zeaxanthin</article-title>. <source>Am J Clin Nutr</source>
<volume>76</volume>, <fpage>595</fpage>&#x02013;<lpage>603</lpage>.<pub-id pub-id-type="pmid">12198005</pub-id></mixed-citation></ref><ref id="ref88"><label>88.</label><mixed-citation publication-type="journal">
<name><surname>Blaak</surname><given-names>E</given-names></name> (<year>2001</year>) <article-title>Gender differences in fat
metabolism</article-title>. <source>Curr Opin Clin Nutr Metab Care</source>
<volume>4</volume>, <fpage>499</fpage>&#x02013;<lpage>502</lpage>.<pub-id pub-id-type="pmid">11706283</pub-id></mixed-citation></ref><ref id="ref89"><label>89.</label><mixed-citation publication-type="journal">
<name><surname>Johnson</surname><given-names>EJ</given-names></name>, <name><surname>Hammond</surname><given-names>BR</given-names></name>, <name><surname>Yeum</surname><given-names>KJ</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Relation among serum and
tissue concentrations of lutein and zeaxanthin and macular pigment
density</article-title>. <source>Am J Clin Nutr</source>
<volume>71</volume>, <fpage>1555</fpage>&#x02013;<lpage>1562</lpage>.<pub-id pub-id-type="pmid">10837298</pub-id></mixed-citation></ref><ref id="ref90"><label>90.</label><mixed-citation publication-type="journal">
<name><surname>Schnohr</surname><given-names>P</given-names></name>, <name><surname>Thomsen</surname><given-names>OO</given-names></name>, <name><surname>Riis</surname><given-names>HP</given-names></name>, <etal>et al</etal> (<year>1994</year>) <article-title>Egg consumption and
high-density-lipoprotein cholesterol</article-title>. <source>J Intern Med</source>
<volume>235</volume>, <fpage>249</fpage>&#x02013;<lpage>251</lpage>.<pub-id pub-id-type="pmid">8120521</pub-id></mixed-citation></ref><ref id="ref91"><label>91.</label><mixed-citation publication-type="journal">
<name><surname>Herron</surname><given-names>KL</given-names></name>, <name><surname>Lofgren</surname><given-names>IE</given-names></name>, <name><surname>Sharman</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>High intake of cholesterol
results in less atherogenic low-density lipoprotein particles in men and women
independent of response classification</article-title>. <source>Metabolism</source>
<volume>53</volume>, <fpage>823</fpage>&#x02013;<lpage>830</lpage>.<pub-id pub-id-type="pmid">15164336</pub-id></mixed-citation></ref><ref id="ref92"><label>92.</label><mixed-citation publication-type="journal">
<name><surname>Nimalaratne</surname><given-names>C</given-names></name>, <name><surname>Savard</surname><given-names>P</given-names></name>, <name><surname>Gauthier</surname><given-names>SF</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Bioaccessibility and
digestive stability of carotenoids in cooked eggs studied using a dynamic <italic>in
vitro</italic> gastrointestinal model</article-title>. <source>J Agric Food Chem</source>
<volume>63</volume>, <fpage>2956</fpage>&#x02013;<lpage>2962</lpage>.<pub-id pub-id-type="pmid">25748723</pub-id></mixed-citation></ref></ref-list></back></article>